-
1
-
-
34247585475
-
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
-
Abbink, P., Lemckert, A. A., Ewald, B. A., Lynch, D. M., Denholtz, M., Smits, S., et al. (2007). Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol. 81, 4654-4663. doi: 10.1128/JVI.02696-06
-
(2007)
J. Virol.
, vol.81
, pp. 4654-4663
-
-
Abbink, P.1
Lemckert, A.A.2
Ewald, B.A.3
Lynch, D.M.4
Denholtz, M.5
Smits, S.6
-
2
-
-
68949215573
-
Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5
-
Abe, S., Okuda, K., Ura, T., Kondo, A., Yoshida, A., Yoshizaki, S., et al. (2009). Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5. J. Gene Med. 11, 570-579. doi: 10.1002/jgm.1332
-
(2009)
J. Gene Med.
, vol.11
, pp. 570-579
-
-
Abe, S.1
Okuda, K.2
Ura, T.3
Kondo, A.4
Yoshida, A.5
Yoshizaki, S.6
-
3
-
-
84886308087
-
A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infants
-
Afolabi, M. O., Ndure, J., Drammeh, A., Darboe, F., Mehedi, S. R., Rowland-Jones, S. L., et al. (2013). A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infants. PLoS ONE 8:e78289. doi: 10.1371/journal.pone.0078289
-
(2013)
PLoS ONE
, vol.8
-
-
Afolabi, M.O.1
Ndure, J.2
Drammeh, A.3
Darboe, F.4
Mehedi, S.R.5
Rowland-Jones, S.L.6
-
4
-
-
33846900938
-
MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study
-
Albarran, Y. C. A., de la Garza, A., Cruz Quiroz, B. J., Vazquez Zea, E., Diaz Estrada, I., Mendez Fuentez, E., et al. (2007). MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study. BioDrugs 21, 47-59. doi: 10.2165/00063030-200721010-00006
-
(2007)
BioDrugs
, vol.21
, pp. 47-59
-
-
Albarran, Y.C.A.1
de la Garza, A.2
Cruz Quiroz, B.J.3
Vazquez Zea, E.4
Diaz Estrada, I.5
Mendez Fuentez, E.6
-
5
-
-
0037695239
-
Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins
-
Albu, D. I., Jones-Trower, A., Woron, A. M., Stellrecht, K., Broder, C. C., and Metzger, D. W. (2003). Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins. J. Virol. 77, 5589-5597. doi: 10.1128/JVI.77.10.5589-5597.2003
-
(2003)
J. Virol.
, vol.77
, pp. 5589-5597
-
-
Albu, D.I.1
Jones-Trower, A.2
Woron, A.M.3
Stellrecht, K.4
Broder, C.C.5
Metzger, D.W.6
-
6
-
-
84891605288
-
Pre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade C
-
Alexander, J., Mendy, J., Vang, L., Avanzini, J. B., Garduno, F., Manayani, D. J., et al. (2013). Pre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade C. PLoS ONE 8:e82380. doi: 10.1371/journal.pone.0082380
-
(2013)
PLoS ONE
, vol.8
-
-
Alexander, J.1
Mendy, J.2
Vang, L.3
Avanzini, J.B.4
Garduno, F.5
Manayani, D.J.6
-
7
-
-
10744224195
-
Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus
-
Anderson, R. J., Hannan, C. M., Gilbert, S. C., Laidlaw, S. M., Sheu, E. G., Korten, S., et al. (2004). Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus. J. Immunol. 172, 3094-3100. doi: 10.4049/jimmunol.172.5.3094
-
(2004)
J. Immunol.
, vol.172
, pp. 3094-3100
-
-
Anderson, R.J.1
Hannan, C.M.2
Gilbert, S.C.3
Laidlaw, S.M.4
Sheu, E.G.5
Korten, S.6
-
8
-
-
0032503233
-
The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses
-
Antoine, G., Scheiflinger, F., Dorner, F., and Falkner, F. G. (1998). The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244, 365-396. doi: 10.1006/viro.1998.9123
-
(1998)
Virology
, vol.244
, pp. 365-396
-
-
Antoine, G.1
Scheiflinger, F.2
Dorner, F.3
Falkner, F.G.4
-
9
-
-
49649109923
-
Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo
-
Appledorn, D. M., Patial, S., McBride, A., Godbehere, S., Van Rooijen, N., Parameswaran, N., et al. (2008). Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J. Immunol. 181, 2134-2144. doi: 10.4049/jimmunol.181.3.2134
-
(2008)
J. Immunol.
, vol.181
, pp. 2134-2144
-
-
Appledorn, D.M.1
Patial, S.2
McBride, A.3
Godbehere, S.4
Van Rooijen, N.5
Parameswaran, N.6
-
10
-
-
24744463560
-
Activation of innate immunity, inflammation, and potentiation of DNA vaccination through mammalian expression of the TLR5 agonist flagellin
-
Applequist, S. E., Rollman, E., Wareing, M. D., Liden, M., Rozell, B., Hinkula, J., et al. (2005). Activation of innate immunity, inflammation, and potentiation of DNA vaccination through mammalian expression of the TLR5 agonist flagellin. J. Immunol. 175, 3882-3891. doi: 10.4049/jimmunol.175.6.3882
-
(2005)
J. Immunol.
, vol.175
, pp. 3882-3891
-
-
Applequist, S.E.1
Rollman, E.2
Wareing, M.D.3
Liden, M.4
Rozell, B.5
Hinkula, J.6
-
11
-
-
77952581247
-
Mucosal HIV vaccines: a holy grail or a dud?
-
Azizi, A., Ghunaim, H., Diaz-Mitoma, F., and Mestecky, J. (2010). Mucosal HIV vaccines: a holy grail or a dud? Vaccine 28, 4015-4026. doi: 10.1016/j.vaccine.2010.04.018
-
(2010)
Vaccine
, vol.28
, pp. 4015-4026
-
-
Azizi, A.1
Ghunaim, H.2
Diaz-Mitoma, F.3
Mestecky, J.4
-
12
-
-
84871769381
-
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)
-
Baden, L. R., Walsh, S. R., Seaman, M. S., Tucker, R. P., Krause, K. H., Patel, A., et al. (2013). First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). J. Infect. Dis. 207, 240-247. doi: 10.1093/infdis/jis670
-
(2013)
J. Infect. Dis.
, vol.207
, pp. 240-247
-
-
Baden, L.R.1
Walsh, S.R.2
Seaman, M.S.3
Tucker, R.P.4
Krause, K.H.5
Patel, A.6
-
13
-
-
80053948074
-
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania
-
Bakari, M., Aboud, S., Nilsson, C., Francis, J., Buma, D., Moshiro, C., et al. (2011). Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania. Vaccine 29, 8417-8428. doi: 10.1016/j.vaccine.2011.08.001
-
(2011)
Vaccine
, vol.29
, pp. 8417-8428
-
-
Bakari, M.1
Aboud, S.2
Nilsson, C.3
Francis, J.4
Buma, D.5
Moshiro, C.6
-
14
-
-
84855466746
-
Antibody-based protection against HIV infection by vectored immunoprophylaxis
-
Balazs, A. B., Chen, J., Hong, C. M., Rao, D. S., Yang, L., and Baltimore, D. (2012). Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature 481, 81-84. doi: 10.1038/nature10660
-
(2012)
Nature
, vol.481
, pp. 81-84
-
-
Balazs, A.B.1
Chen, J.2
Hong, C.M.3
Rao, D.S.4
Yang, L.5
Baltimore, D.6
-
15
-
-
84896120124
-
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
-
Balazs, A. B., Ouyang, Y., Hong, C. M., Chen, J., Nguyen, S. M., Rao, D. S., et al. (2014). Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission. Nat. Med. 20, 296-300. doi: 10.1038/nm.3471
-
(2014)
Nat. Med.
, vol.20
, pp. 296-300
-
-
Balazs, A.B.1
Ouyang, Y.2
Hong, C.M.3
Chen, J.4
Nguyen, S.M.5
Rao, D.S.6
-
16
-
-
31844448804
-
Development of nonhuman adenoviruses as vaccine vectors
-
Bangari, D. S., and Mittal, S. K. (2006). Development of nonhuman adenoviruses as vaccine vectors. Vaccine 24, 849-862. doi: 10.1016/j.vaccine.2005.08.101
-
(2006)
Vaccine
, vol.24
, pp. 849-862
-
-
Bangari, D.S.1
Mittal, S.K.2
-
17
-
-
45749099294
-
Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration
-
Bansal, A., Jackson, B., West, K., Wang, S., Lu, S., Kennedy, J. S., et al. (2008). Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration. J. Virol. 82, 6458-6469. doi: 10.1128/JVI.00068-08
-
(2008)
J. Virol.
, vol.82
, pp. 6458-6469
-
-
Bansal, A.1
Jackson, B.2
West, K.3
Wang, S.4
Lu, S.5
Kennedy, J.S.6
-
18
-
-
84855388574
-
Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man
-
115ra1
-
Barnes, E., Folgori, A., Capone, S., Swadling, L., Aston, S., Kurioka, A., et al. (2012). Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. Sci. Transl. Med. 4, 115ra1. doi: 10.1126/scitranslmed.3003155
-
(2012)
Sci. Transl. Med.
, vol.4
-
-
Barnes, E.1
Folgori, A.2
Capone, S.3
Swadling, L.4
Aston, S.5
Kurioka, A.6
-
19
-
-
79960298256
-
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
-
Barouch, D. H., Kik, S. V., Weverling, G. J., Dilan, R., King, S. L., Maxfield, L. F., et al. (2011). International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine 29, 5203-5209. doi: 10.1016/j.vaccine.2011.05.025
-
(2011)
Vaccine
, vol.29
, pp. 5203-5209
-
-
Barouch, D.H.1
Kik, S.V.2
Weverling, G.J.3
Dilan, R.4
King, S.L.5
Maxfield, L.F.6
-
20
-
-
84856482137
-
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
-
Barouch, D. H., Liu, J., Li, H., Maxfield, L. F., Abbink, P., Lynch, D. M., et al. (2012). Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature 482, 89-93. doi: 10.1038/nature10766
-
(2012)
Nature
, vol.482
, pp. 89-93
-
-
Barouch, D.H.1
Liu, J.2
Li, H.3
Maxfield, L.F.4
Abbink, P.5
Lynch, D.M.6
-
21
-
-
84871724103
-
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001)
-
Barouch, D. H., Liu, J., Peter, L., Abbink, P., Iampietro, M. J., Cheung, A., et al. (2013). Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). J. Infect. Dis. 207, 248-256. doi: 10.1093/infdis/jis671
-
(2013)
J. Infect. Dis.
, vol.207
, pp. 248-256
-
-
Barouch, D.H.1
Liu, J.2
Peter, L.3
Abbink, P.4
Iampietro, M.J.5
Cheung, A.6
-
22
-
-
77949263061
-
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
-
Barouch, D. H., O'Brien, K. L., Simmons, N. L., King, S. L., Abbink, P., Maxfield, L. F., et al. (2010). Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat. Med. 16, 319-323. doi: 10.1038/nm.2089
-
(2010)
Nat. Med.
, vol.16
, pp. 319-323
-
-
Barouch, D.H.1
O'Brien, K.L.2
Simmons, N.L.3
King, S.L.4
Abbink, P.5
Maxfield, L.F.6
-
23
-
-
80053004837
-
Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors
-
Bassett, J. D., Swift, S. L., and Bramson, J. L. (2011). Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors. Expert Rev. Vaccines 10, 1307-1319. doi: 10.1586/erv.11.88
-
(2011)
Expert Rev. Vaccines
, vol.10
, pp. 1307-1319
-
-
Bassett, J.D.1
Swift, S.L.2
Bramson, J.L.3
-
24
-
-
80053360893
-
Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes
-
Bayer, W., Lietz, R., Ontikatze, T., Johrden, L., Tenbusch, M., Nabi, G., et al. (2011). Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes. Retrovirology 8:75. doi: 10.1186/1742-4690-8-75
-
(2011)
Retrovirology
, vol.8
, pp. 75
-
-
Bayer, W.1
Lietz, R.2
Ontikatze, T.3
Johrden, L.4
Tenbusch, M.5
Nabi, G.6
-
25
-
-
40349087409
-
Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya
-
Bejon, P., Ogada, E., Mwangi, T., Milligan, P., Lang, T., Fegan, G., et al. (2007). Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS ONE 2:e707. doi: 10.1371/journal.pone.0000707
-
(2007)
PLoS ONE
, vol.2
-
-
Bejon, P.1
Ogada, E.2
Mwangi, T.3
Milligan, P.4
Lang, T.5
Fegan, G.6
-
26
-
-
7844229165
-
Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers
-
Belshe, R. B., Gorse, G. J., Mulligan, M. J., Evans, T. G., Keefer, M. C., Excler, J. L., et al. (1998). Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group. AIDS 12, 2407-2415.
-
(1998)
NIAID AIDS Vaccine Evaluation Group. AIDS
, vol.12
, pp. 2407-2415
-
-
Belshe, R.B.1
Gorse, G.J.2
Mulligan, M.J.3
Evans, T.G.4
Keefer, M.C.5
Excler, J.L.6
-
27
-
-
0032535760
-
The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12
-
Belyakov, I. M., Ahlers, J. D., Brandwein, B. Y., Earl, P., Kelsall, B. L., Moss, B., et al. (1998b). The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J. Clin. Invest. 102, 2072-2081. doi: 10.1172/JCI5102
-
(1998)
J. Clin. Invest.
, vol.102
, pp. 2072-2081
-
-
Belyakov, I.M.1
Ahlers, J.D.2
Brandwein, B.Y.3
Earl, P.4
Kelsall, B.L.5
Moss, B.6
-
28
-
-
0032539614
-
Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge
-
Belyakov, I. M., Derby, M. A., Ahlers, J. D., Kelsall, B. L., Earl, P., Moss, B., et al. (1998a). Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc. Natl. Acad. Sci. U.S.A. 95, 1709-1714.
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 1709-1714
-
-
Belyakov, I.M.1
Derby, M.A.2
Ahlers, J.D.3
Kelsall, B.L.4
Earl, P.5
Moss, B.6
-
30
-
-
0031052263
-
Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
-
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., et al. (1997). Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323.
-
(1997)
Science
, vol.275
, pp. 1320-1323
-
-
Bergelson, J.M.1
Cunningham, J.A.2
Droguett, G.3
Kurt-Jones, E.A.4
Krithivas, A.5
Hong, J.S.6
-
31
-
-
0037389779
-
Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial
-
Bergman, P. J., McKnight, J., Novosad, A., Charney, S., Farrelly, J., Craft, D., et al. (2003). Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin. Cancer Res. 9, 1284-1290.
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 1284-1290
-
-
Bergman, P.J.1
McKnight, J.2
Novosad, A.3
Charney, S.4
Farrelly, J.5
Craft, D.6
-
32
-
-
79951645476
-
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1
-
Berthoud, T. K., Hamill, M., Lillie, P. J., Hwenda, L., Collins, K. A., Ewer, K. J., et al. (2011). Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin. Infect. Dis. 52, 1-7. doi: 10.1093/cid/ciq015
-
(2011)
Clin. Infect. Dis.
, vol.52
, pp. 1-7
-
-
Berthoud, T.K.1
Hamill, M.2
Lillie, P.J.3
Hwenda, L.4
Collins, K.A.5
Ewer, K.J.6
-
33
-
-
12144289214
-
Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates
-
Bertley, F. M., Kozlowski, P. A., Wang, S. W., Chappelle, J., Patel, J., Sonuyi, O., et al. (2004). Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates. J. Immunol. 172, 3745-3757. doi: 10.4049/jimmunol.172.6.3745
-
(2004)
J. Immunol.
, vol.172
, pp. 3745-3757
-
-
Bertley, F.M.1
Kozlowski, P.A.2
Wang, S.W.3
Chappelle, J.4
Patel, J.5
Sonuyi, O.6
-
34
-
-
81255163699
-
Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus
-
Bilello, J. P., Manrique, J. M., Shin, Y. C., Lauer, W., Li, W., Lifson, J. D., et al. (2011). Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus. J. Virol. 85, 12708-12720. doi: 10.1128/JVI.00865-11
-
(2011)
J. Virol.
, vol.85
, pp. 12708-12720
-
-
Bilello, J.P.1
Manrique, J.M.2
Shin, Y.C.3
Lauer, W.4
Li, W.5
Lifson, J.D.6
-
35
-
-
78149282151
-
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
-
Bodin, K., Ellmerich, S., Kahan, M. C., Tennent, G. A., Loesch, A., Gilbertson, J. A., et al. (2010). Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. Nature 468, 93-97. doi: 10.1038/nature09494
-
(2010)
Nature
, vol.468
, pp. 93-97
-
-
Bodin, K.1
Ellmerich, S.2
Kahan, M.C.3
Tennent, G.A.4
Loesch, A.5
Gilbertson, J.A.6
-
36
-
-
79951754740
-
Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges
-
Bomsel, M., Tudor, D., Drillet, A. S., Alfsen, A., Ganor, Y., Roger, M. G., et al. (2011). Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 34, 269-280. doi: 10.1016/j.immuni.2011.01.015
-
(2011)
Immunity
, vol.34
, pp. 269-280
-
-
Bomsel, M.1
Tudor, D.2
Drillet, A.S.3
Alfsen, A.4
Ganor, Y.5
Roger, M.G.6
-
37
-
-
77949381510
-
Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques
-
Bonaldo, M. C., Martins, M. A., Rudersdorf, R., Mudd, P. A., Sacha, J. B., Piaskowski, S. M., et al. (2010). Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques. J. Virol. 84, 3699-3706. doi: 10.1128/JVI.02255-09
-
(2010)
J. Virol.
, vol.84
, pp. 3699-3706
-
-
Bonaldo, M.C.1
Martins, M.A.2
Rudersdorf, R.3
Mudd, P.A.4
Sacha, J.B.5
Piaskowski, S.M.6
-
38
-
-
84895904764
-
Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1
-
Borthwick, N., Ahmed, T., Ondondo, B., Hayes, P., Rose, A., Ebrahimsa, U., et al. (2014). Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1. Mol. Ther. 22, 464-475. doi: 10.1038/mt.2013.248
-
(2014)
Mol. Ther.
, vol.22
, pp. 464-475
-
-
Borthwick, N.1
Ahmed, T.2
Ondondo, B.3
Hayes, P.4
Rose, A.5
Ebrahimsa, U.6
-
39
-
-
23844496865
-
SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques
-
Boyer, J. D., Robinson, T. M., Kutzler, M. A., Parkinson, R., Calarota, S. A., Sidhu, M. K., et al. (2005). SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques. J. Med. Primatol. 34, 262-270. doi: 10.1111/j.1600-0684.2005.00124.x
-
(2005)
J. Med. Primatol.
, vol.34
, pp. 262-270
-
-
Boyer, J.D.1
Robinson, T.M.2
Kutzler, M.A.3
Parkinson, R.4
Calarota, S.A.5
Sidhu, M.K.6
-
40
-
-
0036140236
-
Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization
-
Bradney, C. P., Sempowski, G. D., Liao, H. X., Haynes, B. F., and Staats, H. F. (2002). Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization. J. Virol. 76, 517-524. doi: 10.1128/JVI.76.2.517-524.2002
-
(2002)
J. Virol.
, vol.76
, pp. 517-524
-
-
Bradney, C.P.1
Sempowski, G.D.2
Liao, H.X.3
Haynes, B.F.4
Staats, H.F.5
-
41
-
-
78649658963
-
Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation
-
Brave, A., Gudmundsdotter, L., Sandstrom, E., Haller, B. K., Hallengard, D., Maltais, A. K., et al. (2010). Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation. Vaccine 28, 8203-8209. doi: 10.1016/j.vaccine.2010.08.108
-
(2010)
Vaccine
, vol.28
, pp. 8203-8209
-
-
Brave, A.1
Gudmundsdotter, L.2
Sandstrom, E.3
Haller, B.K.4
Hallengard, D.5
Maltais, A.K.6
-
43
-
-
84883284588
-
Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors
-
Bruder, J. T., Chen, P., Semenova, E., Thomas, C. A., Konovalova, S., Ekberg, G., et al. (2013). Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors. J. Virol. 87, 9661-9671. doi: 10.1128/JVI.00462-13
-
(2013)
J. Virol.
, vol.87
, pp. 9661-9671
-
-
Bruder, J.T.1
Chen, P.2
Semenova, E.3
Thomas, C.A.4
Konovalova, S.5
Ekberg, G.6
-
44
-
-
84859345005
-
Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses
-
Bruder, J. T., Semenova, E., Chen, P., Limbach, K., Patterson, N. B., Stefaniak, M. E., et al. (2012). Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses. PLoS ONE 7:e33920. doi: 10.1371/journal.pone.0033920
-
(2012)
PLoS ONE
, vol.7
-
-
Bruder, J.T.1
Semenova, E.2
Chen, P.3
Limbach, K.4
Patterson, N.B.5
Stefaniak, M.E.6
-
45
-
-
56649105122
-
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
-
Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., et al. (2008). Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372, 1881-1893. doi: 10.1016/S0140-6736(08)61591-3
-
(2008)
Lancet
, vol.372
, pp. 1881-1893
-
-
Buchbinder, S.P.1
Mehrotra, D.V.2
Duerr, A.3
Fitzgerald, D.W.4
Mogg, R.5
Li, D.6
-
46
-
-
0030891509
-
Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector
-
Caley, I. J., Betts, M. R., Irlbeck, D. M., Davis, N. L., Swanstrom, R., Frelinger, J. A., et al. (1997). Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J. Virol. 71, 3031-3038
-
(1997)
J. Virol.
, vol.71
, pp. 3031-3038
-
-
Caley, I.J.1
Betts, M.R.2
Irlbeck, D.M.3
Davis, N.L.4
Swanstrom, R.5
Frelinger, J.A.6
-
47
-
-
78649714536
-
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
-
Capone, S., Reyes-Sandoval, A., Naddeo, M., Siani, L., Ammendola, V., Rollier, C. S., et al. (2010). Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates. Vaccine 29, 256-265. doi: 10.1016/j.vaccine.2010.10.041
-
(2010)
Vaccine
, vol.29
, pp. 256-265
-
-
Capone, S.1
Reyes-Sandoval, A.2
Naddeo, M.3
Siani, L.4
Ammendola, V.5
Rollier, C.S.6
-
48
-
-
0031585552
-
Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line
-
Carroll, M. W., and Moss, B. (1997). Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line. Virology 238, 198-211. doi: 10.1006/viro.1997.8845
-
(1997)
Virology
, vol.238
, pp. 198-211
-
-
Carroll, M.W.1
Moss, B.2
-
49
-
-
4644225721
-
Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors
-
Casimiro, D. R., Bett, A. J., Fu, T. M., Davies, M. E., Tang, A., Wilson, K. A., et al. (2004). Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors. J. Virol. 78, 11434-11438. doi: 10.1128/JVI.78.20.11434-11438.2004
-
(2004)
J. Virol.
, vol.78
, pp. 11434-11438
-
-
Casimiro, D.R.1
Bett, A.J.2
Fu, T.M.3
Davies, M.E.4
Tang, A.5
Wilson, K.A.6
-
50
-
-
0038664390
-
Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene
-
Casimiro, D. R., Chen, L., Fu, T. M., Evans, R. K., Caulfield, M. J., Davies, M. E., et al. (2003a). Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 77, 6305-6313. doi: 10.1128/JVI.77.11.6305-6313.2003
-
(2003)
J. Virol.
, vol.77
, pp. 6305-6313
-
-
Casimiro, D.R.1
Chen, L.2
Fu, T.M.3
Evans, R.K.4
Caulfield, M.J.5
Davies, M.E.6
-
51
-
-
0037790903
-
Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene
-
Casimiro, D. R., Tang, A., Chen, L., Fu, T. M., Evans, R. K., Davies, M. E., et al. (2003b). Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 77, 7663-7668. doi: 10.1128/JVI.77.13.7663-7668.2003
-
(2003)
J. Virol.
, vol.77
, pp. 7663-7668
-
-
Casimiro, D.R.1
Tang, A.2
Chen, L.3
Fu, T.M.4
Evans, R.K.5
Davies, M.E.6
-
52
-
-
33845439080
-
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector
-
Catanzaro, A. T., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., et al. (2006). Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. J. Infect. Dis. 194, 1638-1649. doi: 10.1086/509258
-
(2006)
J. Infect. Dis.
, vol.194
, pp. 1638-1649
-
-
Catanzaro, A.T.1
Koup, R.A.2
Roederer, M.3
Bailer, R.T.4
Enama, M.E.5
Moodie, Z.6
-
53
-
-
0033571730
-
Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial
-
Cerwenka, A., Morgan, T. M., and Dutton, R. W. (1999). Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J. Immunol. 163, 5535-5543.
-
(1999)
J. Immunol.
, vol.163
, pp. 5535-5543
-
-
Cerwenka, A.1
Morgan, T.M.2
Dutton, R.W.3
-
54
-
-
84905436433
-
Induction of potent and long-lived antibody and cellular immune responses in the genitorectal mucosa could be the critical determinant of HIV vaccine efficacy
-
Chanzu, N., and Ondondo, B. (2014). Induction of potent and long-lived antibody and cellular immune responses in the genitorectal mucosa could be the critical determinant of HIV vaccine efficacy. Front. Immunol. 5:202. doi: 10.3389/fimmu.2014.00202
-
(2014)
Front. Immunol.
, vol.5
, pp. 202
-
-
Chanzu, N.1
Ondondo, B.2
-
55
-
-
77957204031
-
Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae
-
Chen, H., Xiang, Z. Q., Li, Y., Kurupati, R. K., Jia, B., Bian, A., et al. (2010). Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae. J. Virol. 84, 10522-10532. doi: 10.1128/JVI.00450-10
-
(2010)
J. Virol.
, vol.84
, pp. 10522-10532
-
-
Chen, H.1
Xiang, Z.Q.2
Li, Y.3
Kurupati, R.K.4
Jia, B.5
Bian, A.6
-
56
-
-
34249689699
-
Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques
-
Chong, S. Y., Egan, M. A., Kutzler, M. A., Megati, S., Masood, A., Roopchard, V., et al. (2007). Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. Vaccine 25, 4967-4982. doi: 10.1016/j.vaccine.2006.11.070
-
(2007)
Vaccine
, vol.25
, pp. 4967-4982
-
-
Chong, S.Y.1
Egan, M.A.2
Kutzler, M.A.3
Megati, S.4
Masood, A.5
Roopchard, V.6
-
57
-
-
84874015160
-
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity
-
Chuang, I., Sedegah, M., Cicatelli, S., Spring, M., Polhemus, M., Tamminga, C., et al. (2013). DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity. PLoS ONE 8:e55571. doi: 10.1371/journal.pone.0055571
-
(2013)
PLoS ONE
, vol.8
-
-
Chuang, I.1
Sedegah, M.2
Cicatelli, S.3
Spring, M.4
Polhemus, M.5
Tamminga, C.6
-
58
-
-
84855372641
-
Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species
-
115ra2
-
Colloca, S., Barnes, E., Folgori, A., Ammendola, V., Capone, S., Cirillo, A., et al. (2012). Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species. Sci. Transl. Med. 4, 115ra2. doi: 10.1126/scitranslmed.3002925
-
(2012)
Sci. Transl. Med.
, vol.4
-
-
Colloca, S.1
Barnes, E.2
Folgori, A.3
Ammendola, V.4
Capone, S.5
Cirillo, A.6
-
59
-
-
2442515370
-
Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus
-
Corona Gutierrez, C. M., Tinoco, A., Navarro, T., Contreras, M. L., Cortes, R. R., Calzado, P., et al. (2004). Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus. Hum. Gene Ther. 15, 421-431. doi: 10.1089/10430340460745757
-
(2004)
Hum. Gene Ther.
, vol.15
, pp. 421-431
-
-
Corona Gutierrez, C.M.1
Tinoco, A.2
Navarro, T.3
Contreras, M.L.4
Cortes, R.R.5
Calzado, P.6
-
60
-
-
78651250984
-
Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
-
Cristillo, A. D., Ferrari, M. G., Hudacik, L., Lewis, B., Galmin, L., Bowen, B., et al. (2011). Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations. J. Gen. Virol. 92(Pt 1), 128-140. doi: 10.1099/vir.0.023242-0
-
(2011)
J. Gen. Virol.
, vol.92
, pp. 128-140
-
-
Cristillo, A.D.1
Ferrari, M.G.2
Hudacik, L.3
Lewis, B.4
Galmin, L.5
Bowen, B.6
-
61
-
-
37349084570
-
Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation
-
Cristillo, A. D., Weiss, D., Hudacik, L., Restrepo, S., Galmin, L., Suschak, J., et al. (2008). Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation. Biochem. Biophys. Res. Commun. 366, 29-35. doi: 10.1016/j.bbrc.2007.11.052
-
(2008)
Biochem. Biophys. Res. Commun.
, vol.366
, pp. 29-35
-
-
Cristillo, A.D.1
Weiss, D.2
Hudacik, L.3
Restrepo, S.4
Galmin, L.5
Suschak, J.6
-
62
-
-
84856181011
-
Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues
-
Czerkinsky, C., and Holmgren, J. (2012). Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues. Curr. Top. Microbiol. Immunol. 354, 1-18. doi: 10.1007/82_2010_112
-
(2012)
Curr. Top. Microbiol. Immunol.
, vol.354
, pp. 1-18
-
-
Czerkinsky, C.1
Holmgren, J.2
-
63
-
-
0141886316
-
Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge
-
Daftarian, P., Ali, S., Sharan, R., Lacey, S. F., La Rosa, C., Longmate, J., et al. (2003). Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge. J. Immunol. 171, 4028-4039. doi: 10.4049/jimmunol.171.8.4028
-
(2003)
J. Immunol.
, vol.171
, pp. 4028-4039
-
-
Daftarian, P.1
Ali, S.2
Sharan, R.3
Lacey, S.F.4
La Rosa, C.5
Longmate, J.6
-
64
-
-
0035051928
-
West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays
-
Davis, B. S., Chang, G. J., Cropp, B., Roehrig, J. T., Martin, D. A., Mitchell, C. J., et al. (2001). West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75, 4040-4047. doi: 10.1128/JVI.75.9.4040-4047.2001
-
(2001)
J. Virol.
, vol.75
, pp. 4040-4047
-
-
Davis, B.S.1
Chang, G.J.2
Cropp, B.3
Roehrig, J.T.4
Martin, D.A.5
Mitchell, C.J.6
-
65
-
-
84863734927
-
A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity
-
Dicks, M. D., Spencer, A. J., Edwards, N. J., Wadell, G., Bojang, K., Gilbert, S. C., et al. (2012). A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity. PLoS ONE 7:e40385. doi: 10.1371/journal.pone.0040385
-
(2012)
PLoS ONE
, vol.7
-
-
Dicks, M.D.1
Spencer, A.J.2
Edwards, N.J.3
Wadell, G.4
Bojang, K.5
Gilbert, S.C.6
-
66
-
-
33646449925
-
Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine
-
Dorrell, L., Yang, H., Ondondo, B., Dong, T., di Gleria, K., Suttill, A., et al. (2006). Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine. J. Virol. 80, 4705-4716. doi: 10.1128/JVI.80.10.4705-4716.2006
-
(2006)
J. Virol.
, vol.80
, pp. 4705-4716
-
-
Dorrell, L.1
Yang, H.2
Ondondo, B.3
Dong, T.4
di Gleria, K.5
Suttill, A.6
-
67
-
-
33646830816
-
Epidermal DNA vaccine for influenza is immunogenic in humans
-
Drape, R. J., Macklin, M. D., Barr, L. J., Jones, S., Haynes, J. R., and Dean, H. J. (2006). Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine 24, 4475-4481. doi: 10.1016/j.vaccine.2005.08.012
-
(2006)
Vaccine
, vol.24
, pp. 4475-4481
-
-
Drape, R.J.1
Macklin, M.D.2
Barr, L.J.3
Jones, S.4
Haynes, J.R.5
Dean, H.J.6
-
68
-
-
78650655421
-
Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines
-
Draper, S. J., Biswas, S., Spencer, A. J., Remarque, E. J., Capone, S., Naddeo, M., et al. (2010). Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines. J. Immunol. 185, 7583-7595. doi: 10.4049/jimmunol.1001760
-
(2010)
J. Immunol.
, vol.185
, pp. 7583-7595
-
-
Draper, S.J.1
Biswas, S.2
Spencer, A.J.3
Remarque, E.J.4
Capone, S.5
Naddeo, M.6
-
69
-
-
84882916976
-
Utilizing poxviral vectored vaccines for antibody induction-progress and prospects
-
Draper, S. J., Cottingham, M. G., and Gilbert, S. C. (2013). Utilizing poxviral vectored vaccines for antibody induction-progress and prospects. Vaccine 31, 4223-4230. doi: 10.1016/j.vaccine.2013.05.091
-
(2013)
Vaccine
, vol.31
, pp. 4223-4230
-
-
Draper, S.J.1
Cottingham, M.G.2
Gilbert, S.C.3
-
70
-
-
49149104386
-
Effective induction of high-titer antibodies by viral vector vaccines
-
Draper, S. J., Moore, A. C., Goodman, A. L., Long, C. A., Holder, A. A., Gilbert, S. C., et al. (2008). Effective induction of high-titer antibodies by viral vector vaccines. Nat. Med. 14, 819-821. doi: 10.1038/nm.1850
-
(2008)
Nat. Med.
, vol.14
, pp. 819-821
-
-
Draper, S.J.1
Moore, A.C.2
Goodman, A.L.3
Long, C.A.4
Holder, A.A.5
Gilbert, S.C.6
-
71
-
-
0037108812
-
Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge
-
Dumais, N., Patrick, A., Moss, R. B., Davis, H. L., and Rosenthal, K. L. (2002). Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge. J. Infect. Dis. 186, 1098-1105. doi: 10.1086/344232
-
(2002)
J. Infect. Dis.
, vol.186
, pp. 1098-1105
-
-
Dumais, N.1
Patrick, A.2
Moss, R.B.3
Davis, H.L.4
Rosenthal, K.L.5
-
72
-
-
33749235904
-
A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge
-
Dunachie, S. J., Walther, M., Epstein, J. E., Keating, S., Berthoud, T., Andrews, L., et al. (2006). A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge. Infect. Immun. 74, 5933-5942. doi: 10.1128/IAI.00590-06
-
(2006)
Infect. Immun.
, vol.74
, pp. 5933-5942
-
-
Dunachie, S.J.1
Walther, M.2
Epstein, J.E.3
Keating, S.4
Berthoud, T.5
Andrews, L.6
-
73
-
-
23444460831
-
Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus
-
Egan, M. A., Chong, S. Y., Megati, S., Montefiori, D. C., Rose, N. F., Boyer, J. D., et al. (2005). Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. AIDS Res. Hum. Retroviruses 21, 629-643. doi: 10.1089/aid.2005.21.629
-
(2005)
AIDS Res. Hum. Retroviruses
, vol.21
, pp. 629-643
-
-
Egan, M.A.1
Chong, S.Y.2
Megati, S.3
Montefiori, D.C.4
Rose, N.F.5
Boyer, J.D.6
-
74
-
-
5644258446
-
Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes
-
Egan, M. A., Chong, S. Y., Rose, N. F., Megati, S., Lopez, K. J., Schadeck, E. B., et al. (2004). Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes. AIDS Res. Hum. Retroviruses 20, 989-1004. doi: 10.1089/0889222042222746
-
(2004)
AIDS Res. Hum. Retroviruses
, vol.20
, pp. 989-1004
-
-
Egan, M.A.1
Chong, S.Y.2
Rose, N.F.3
Megati, S.4
Lopez, K.J.5
Schadeck, E.B.6
-
75
-
-
3042569691
-
AIDS/HIV
-
Emini, E. A., and Koff, W. C. (2004). AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope. Science 304, 1913-1914. doi: 10.1126/science.1100368
-
(2004)
Developing an AIDS vaccine: need, uncertainty, hope. Science
, vol.304
, pp. 1913-1914
-
-
Emini, E.A.1
Koff, W.C.2
-
76
-
-
77956934789
-
Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys
-
Ersching, J., Hernandez, M. I., Cezarotto, F. S., Ferreira, J. D., Martins, A. B., Switzer, W. M., et al. (2010). Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys. Virology 407, 1-6. doi: 10.1016/j.virol.2010.07.043
-
(2010)
Virology
, vol.407
, pp. 1-6
-
-
Ersching, J.1
Hernandez, M.I.2
Cezarotto, F.S.3
Ferreira, J.D.4
Martins, A.B.5
Switzer, W.M.6
-
77
-
-
0036157469
-
Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population
-
Estcourt, M. J., Ramsay, A. J., Brooks, A., Thomson, S. A., Medveckzy, C. J., and Ramshaw, I. A. (2002). Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population. Int. Immunol. 14, 31-37. doi: 10.1093/intimm/14.1.31
-
(2002)
Int. Immunol.
, vol.14
, pp. 31-37
-
-
Estcourt, M.J.1
Ramsay, A.J.2
Brooks, A.3
Thomson, S.A.4
Medveckzy, C.J.5
Ramshaw, I.A.6
-
78
-
-
0033496071
-
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers
-
Evans, T. G., Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., et al. (1999). A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. J. Infect. Dis. 180, 290-298. doi: 10.1086/314895
-
(1999)
J. Infect. Dis.
, vol.180
, pp. 290-298
-
-
Evans, T.G.1
Keefer, M.C.2
Weinhold, K.J.3
Wolff, M.4
Montefiori, D.5
Gorse, G.J.6
-
79
-
-
77955272708
-
Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference
-
Excler, J. L., Parks, C. L., Ackland, J., Rees, H., Gust, I. D., and Koff, W. C. (2010). Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference. Biologicals 38, 511-521. doi: 10.1016/j.biologicals.2010.03.005
-
(2010)
Biologicals
, vol.38
, pp. 511-521
-
-
Excler, J.L.1
Parks, C.L.2
Ackland, J.3
Rees, H.4
Gust, I.D.5
Koff, W.C.6
-
80
-
-
70649094217
-
Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge
-
Faul, E. J., Aye, P. P., Papaneri, A. B., Pahar, B., McGettigan, J. P., Schiro, F., et al. (2009). Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge. Vaccine 28, 299-308. doi: 10.1016/j.vaccine.2009.10.051
-
(2009)
Vaccine
, vol.28
, pp. 299-308
-
-
Faul, E.J.1
Aye, P.P.2
Papaneri, A.B.3
Pahar, B.4
McGettigan, J.P.5
Schiro, F.6
-
81
-
-
70450184456
-
Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus
-
Finn, J. D., Bassett, J., Millar, J. B., Grinshtein, N., Yang, T. C., Parsons, R., et al. (2009). Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus. J. Virol. 83, 12027-12036. doi: 10.1128/JVI.00593-09
-
(2009)
J. Virol.
, vol.83
, pp. 12027-12036
-
-
Finn, J.D.1
Bassett, J.2
Millar, J.B.3
Grinshtein, N.4
Yang, T.C.5
Parsons, R.6
-
82
-
-
0037310512
-
A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag
-
Fitzgerald, J. C., Gao, G. P., Reyes-Sandoval, A., Pavlakis, G. N., Xiang, Z. Q., Wlazlo, A. P., et al. (2003). A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. J. Immunol. 170, 1416-1422. doi: 10.4049/jimmunol.170.3.1416
-
(2003)
J. Immunol.
, vol.170
, pp. 1416-1422
-
-
Fitzgerald, J.C.1
Gao, G.P.2
Reyes-Sandoval, A.3
Pavlakis, G.N.4
Xiang, Z.Q.5
Wlazlo, A.P.6
-
83
-
-
13944254982
-
Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection
-
Flynn, N. M., Forthal, D. N., Harro, C. D., Judson, F. N., Mayer, K. H., Para, M. F., et al. (2005). Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J. Infect. Dis. 191, 654-665. doi: 10.1086/428404
-
(2005)
J. Infect. Dis.
, vol.191
, pp. 654-665
-
-
Flynn, N.M.1
Forthal, D.N.2
Harro, C.D.3
Judson, F.N.4
Mayer, K.H.5
Para, M.F.6
-
84
-
-
84855445252
-
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine
-
Frahm, N., DeCamp, A. C., Friedrich, D. P., Carter, D. K., Defawe, O. D., Kublin, J. G., et al. (2012). Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. J. Clin. Invest. 122, 359-367. doi: 10.1172/JCI60202
-
(2012)
J. Clin. Invest.
, vol.122
, pp. 359-367
-
-
Frahm, N.1
DeCamp, A.C.2
Friedrich, D.P.3
Carter, D.K.4
Defawe, O.D.5
Kublin, J.G.6
-
85
-
-
84883441968
-
First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine
-
Fuchs, J., Frank, I., Kochar, N., Elizaga, M., Allen, M., Carter, D., et al. (2012). First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine. Retrovirology 9, P134. doi: 10.1186/1742-4690-9-S2-P134
-
(2012)
Retrovirology
, vol.9
, pp. P134
-
-
Fuchs, J.1
Frank, I.2
Kochar, N.3
Elizaga, M.4
Allen, M.5
Carter, D.6
-
86
-
-
84987797897
-
-
Barcelona: AIDS vaccine
-
Fuchs, J., Frank, I., Kochar, N., Elizaga, M., Allen, M., Frahm, N., et al. (2013). A Recombinant Vesicular Stomatitis Virus (rVSV) HIV-1 gag Vaccine is Safe And Immunogenic in Healthy, HIV-1 Uninfected Phase I Trial Participants. Barcelona: AIDS vaccine.
-
(2013)
A Recombinant Vesicular Stomatitis Virus (rVSV) HIV-1 gag Vaccine is Safe And Immunogenic in Healthy, HIV-1 Uninfected Phase I Trial Participants
-
-
Fuchs, J.1
Frank, I.2
Kochar, N.3
Elizaga, M.4
Allen, M.5
Frahm, N.6
-
87
-
-
70350070724
-
Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
-
Gabitzsch, E. S., Xu, Y., Yoshida, L. H., Balint, J., Amalfitano, A., and Jones, F. R. (2009). Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity. Vaccine 27, 6394-6398. doi: 10.1016/j.vaccine.2009.06.028
-
(2009)
Vaccine
, vol.27
, pp. 6394-6398
-
-
Gabitzsch, E.S.1
Xu, Y.2
Yoshida, L.H.3
Balint, J.4
Amalfitano, A.5
Jones, F.R.6
-
89
-
-
80054003999
-
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: a phase I clinical trial (RISVAC02)
-
Garcia, F., Bernaldo de Quiros, J. C., Gomez, C. E., Perdiguero, B., Najera, J. L., Jimenez, V., et al. (2011). Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: a phase I clinical trial (RISVAC02). Vaccine 29, 8309-8316. doi: 10.1016/j.vaccine.2011.08.098
-
(2011)
Vaccine
, vol.29
, pp. 8309-8316
-
-
Garcia, F.1
Bernaldo de Quiros, J.C.2
Gomez, C.E.3
Perdiguero, B.4
Najera, J.L.5
Jimenez, V.6
-
90
-
-
84879530209
-
Improving adaptive and memory immune responses of an HIV/AIDS Vaccine Candidate MVA-B by deletion of vaccinia virus genes (C6L and K7R) blocking interferon signaling pathways
-
Garcia-Arriaza, J., Arnaez, P., Gomez, C. E., Sorzano, C. O., and Esteban, M. (2013). Improving adaptive and memory immune responses of an HIV/AIDS Vaccine Candidate MVA-B by deletion of vaccinia virus genes (C6L and K7R) blocking interferon signaling pathways. PLoS ONE 8:e66894. doi: 10.1371/journal.pone.0066894
-
(2013)
PLoS ONE
, vol.8
-
-
Garcia-Arriaza, J.1
Arnaez, P.2
Gomez, C.E.3
Sorzano, C.O.4
Esteban, M.5
-
91
-
-
33646817087
-
Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine
-
Garcia-Hernandez, E., Gonzalez-Sanchez, J. L., Andrade-Manzano, A., Contreras, M. L., Padilla, S., Guzman, C. C., et al. (2006). Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine. Cancer Gene Ther. 13, 592-597. doi: 10.1038/sj.cgt.7700937
-
(2006)
Cancer Gene Ther.
, vol.13
, pp. 592-597
-
-
Garcia-Hernandez, E.1
Gonzalez-Sanchez, J.L.2
Andrade-Manzano, A.3
Contreras, M.L.4
Padilla, S.5
Guzman, C.C.6
-
93
-
-
18444409072
-
Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon
-
Garver, K. A., LaPatra, S. E., and Kurath, G. (2005). Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon. Dis. Aquat. Organ. 64, 13-22. doi: 10.3354/dao064013
-
(2005)
Dis. Aquat. Organ.
, vol.64
, pp. 13-22
-
-
Garver, K.A.1
LaPatra, S.E.2
Kurath, G.3
-
94
-
-
0033525799
-
Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants
-
Gherardi, M. M., and Esteban, M. (1999). Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants. Vaccine 17, 1074-1083.
-
(1999)
Vaccine
, vol.17
, pp. 1074-1083
-
-
Gherardi, M.M.1
Esteban, M.2
-
95
-
-
27644592654
-
Recombinant poxviruses as mucosal vaccine vectors
-
Gherardi, M. M., and Esteban, M. (2005). Recombinant poxviruses as mucosal vaccine vectors. J. Gen. Virol. 86(Pt 11), 2925-2936. doi: 10.1099/vir.0.81181-0
-
(2005)
J. Gen. Virol.
, vol.86
, pp. 2925-2936
-
-
Gherardi, M.M.1
Esteban, M.2
-
96
-
-
0038279752
-
Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes
-
Gherardi, M. M., Najera, J. L., Perez-Jimenez, E., Guerra, S., Garcia-Sastre, A., and Esteban, M. (2003). Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes. J. Virol. 77, 7048-7057. doi: 10.1128/JVI.77.12.7048-7057.2003
-
(2003)
J. Virol.
, vol.77
, pp. 7048-7057
-
-
Gherardi, M.M.1
Najera, J.L.2
Perez-Jimenez, E.3
Guerra, S.4
Garcia-Sastre, A.5
Esteban, M.6
-
97
-
-
2442517281
-
Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule
-
Gherardi, M. M., Perez-Jimenez, E., Najera, J. L., and Esteban, M. (2004). Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule. J. Immunol. 172, 6209-6220. doi: 10.4049/jimmunol.172.10.6209
-
(2004)
J. Immunol.
, vol.172
, pp. 6209-6220
-
-
Gherardi, M.M.1
Perez-Jimenez, E.2
Najera, J.L.3
Esteban, M.4
-
98
-
-
0343517098
-
Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide
-
Gherardi, M. M., Ramirez, J. C., and Esteban, M. (2000). Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide. J. Virol. 74, 6278-6286. doi: 10.1128/JVI.74.14.6278-6286.2000
-
(2000)
J. Virol.
, vol.74
, pp. 6278-6286
-
-
Gherardi, M.M.1
Ramirez, J.C.2
Esteban, M.3
-
99
-
-
0033151996
-
IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner
-
Gherardi, M. M., Ramirez, J. C., Rodriguez, D., Rodriguez, J. R., Sano, G., Zavala, F., et al. (1999). IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner. J. Immunol. 162, 6724-6733.
-
(1999)
J. Immunol.
, vol.162
, pp. 6724-6733
-
-
Gherardi, M.M.1
Ramirez, J.C.2
Rodriguez, D.3
Rodriguez, J.R.4
Sano, G.5
Zavala, F.6
-
100
-
-
13944250922
-
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
-
Gilbert, P. B., Peterson, M. L., Follmann, D., Hudgens, M. G., Francis, D. P., Gurwith, M., et al. (2005). Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J. Infect. Dis. 191, 666-677. doi: 10.1086/428405
-
(2005)
J. Infect. Dis.
, vol.191
, pp. 666-677
-
-
Gilbert, P.B.1
Peterson, M.L.2
Follmann, D.3
Hudgens, M.G.4
Francis, D.P.5
Gurwith, M.6
-
101
-
-
0037081381
-
Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes
-
Gilbert, S. C., Schneider, J., Hannan, C. M., Hu, J. T., Plebanski, M., Sinden, R., et al. (2002). Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. Vaccine 20, 1039-1045. doi: 10.1016/S0264-410X(01)00450-9
-
(2002)
Vaccine
, vol.20
, pp. 1039-1045
-
-
Gilbert, S.C.1
Schneider, J.2
Hannan, C.M.3
Hu, J.T.4
Plebanski, M.5
Sinden, R.6
-
102
-
-
0033005077
-
Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations
-
Gilbert, S. C., Schneider, J., Plebanski, M., Hannan, C. M., Blanchard, T. J., Smith, G. L., et al. (1999). Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations. Biol. Chem. 380, 299-303. doi: 10.1515/BC.1999.041
-
(1999)
Biol. Chem.
, vol.380
, pp. 299-303
-
-
Gilbert, S.C.1
Schneider, J.2
Plebanski, M.3
Hannan, C.M.4
Blanchard, T.J.5
Smith, G.L.6
-
103
-
-
76449109014
-
Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis
-
Gillmore, J. D., Tennent, G. A., Hutchinson, W. L., Gallimore, J. R., Lachmann, H. J., Goodman, H. J., et al. (2010). Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis. Br. J. Haematol. 148, 760-767. doi: 10.1111/j.1365-2141.2009.08036.x
-
(2010)
Br. J. Haematol.
, vol.148
, pp. 760-767
-
-
Gillmore, J.D.1
Tennent, G.A.2
Hutchinson, W.L.3
Gallimore, J.R.4
Lachmann, H.J.5
Goodman, H.J.6
-
104
-
-
79751487021
-
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles
-
Goepfert, P. A., Elizaga, M. L., Sato, A., Qin, L., Cardinali, M., Hay, C. M., et al. (2011). Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. J. Infect. Dis. 203, 610-619. doi: 10.1093/infdis/jiq105
-
(2011)
J. Infect. Dis.
, vol.203
, pp. 610-619
-
-
Goepfert, P.A.1
Elizaga, M.L.2
Sato, A.3
Qin, L.4
Cardinali, M.5
Hay, C.M.6
-
105
-
-
80055120690
-
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens
-
Gomez, C. E., Najera, J. L., Perdiguero, B., Garcia-Arriaza, J., Sorzano, C. O., Jimenez, V., et al. (2011). The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens. J. Virol. 85, 11468-11478. doi: 10.1128/JVI.05165-11
-
(2011)
J. Virol.
, vol.85
, pp. 11468-11478
-
-
Gomez, C.E.1
Najera, J.L.2
Perdiguero, B.3
Garcia-Arriaza, J.4
Sorzano, C.O.5
Jimenez, V.6
-
106
-
-
84861304314
-
Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice
-
Gomez, C. E., Perdiguero, B., Najera, J. L., Sorzano, C. O., Jimenez, V., Gonzalez-Sanz, R., et al. (2012). Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice. J. Virol. 86, 5026-5038. doi: 10.1128/JVI.06684-11
-
(2012)
J. Virol.
, vol.86
, pp. 5026-5038
-
-
Gomez, C.E.1
Perdiguero, B.2
Najera, J.L.3
Sorzano, C.O.4
Jimenez, V.5
Gonzalez-Sanz, R.6
-
107
-
-
33646454992
-
Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes
-
Goonetilleke, N., Moore, S., Dally, L., Winstone, N., Cebere, I., Mahmoud, A., et al. (2006). Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes. J. Virol. 80, 4717-4728. doi: 10.1128/JVI.80.10.4717-4728.2006
-
(2006)
J. Virol.
, vol.80
, pp. 4717-4728
-
-
Goonetilleke, N.1
Moore, S.2
Dally, L.3
Winstone, N.4
Cebere, I.5
Mahmoud, A.6
-
108
-
-
84876002357
-
DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial
-
Graham, B. S., Enama, M. E., Nason, M. C., Gordon, I. J., Peel, S. A., Ledgerwood, J. E., et al. (2013). DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial. PLoS ONE 8:e59340. doi: 10.1371/journal.pone.0059340
-
(2013)
PLoS ONE
, vol.8
-
-
Graham, B.S.1
Enama, M.E.2
Nason, M.C.3
Gordon, I.J.4
Peel, S.A.5
Ledgerwood, J.E.6
-
109
-
-
33845412550
-
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine
-
Graham, B. S., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., et al. (2006). Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. J. Infect. Dis. 194, 1650-1660. doi: 10.1086/509259
-
(2006)
J. Infect. Dis.
, vol.194
, pp. 1650-1660
-
-
Graham, B.S.1
Koup, R.A.2
Roederer, M.3
Bailer, R.T.4
Enama, M.E.5
Moodie, Z.6
-
110
-
-
79959301474
-
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
-
Gray, G. E., Allen, M., Moodie, Z., Churchyard, G., Bekker, L. G., Nchabeleng, M., et al. (2011). Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect. Dis. 11, 507-515. doi: 10.1016/S1473-3099
-
(2011)
Lancet Infect. Dis.
, vol.11
, pp. 507-515
-
-
Gray, G.E.1
Allen, M.2
Moodie, Z.3
Churchyard, G.4
Bekker, L.G.5
Nchabeleng, M.6
-
111
-
-
56649097350
-
Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy
-
Greenough, T. C., Cunningham, C. K., Muresan, P., McManus, M., Persaud, D., Fenton, T., et al. (2008). Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy. Vaccine 26, 6883-6893. doi: 10.1016/j.vaccine.2008.09.084
-
(2008)
Vaccine
, vol.26
, pp. 6883-6893
-
-
Greenough, T.C.1
Cunningham, C.K.2
Muresan, P.3
McManus, M.4
Persaud, D.5
Fenton, T.6
-
112
-
-
67649338409
-
Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity
-
Gudmundsdotter, L., Nilsson, C., Brave, A., Hejdeman, B., Earl, P., Moss, B., et al. (2009). Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity. Vaccine 27, 4468-4474. doi: 10.1016/j.vaccine.2009.05.018
-
(2009)
Vaccine
, vol.27
, pp. 4468-4474
-
-
Gudmundsdotter, L.1
Nilsson, C.2
Brave, A.3
Hejdeman, B.4
Earl, P.5
Moss, B.6
-
113
-
-
58149204280
-
Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers
-
Guimaraes-Walker, A., Mackie, N., McCormack, S., Hanke, T., Schmidt, C., Gilmour, J., et al. (2008). Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers. Vaccine 26, 6671-6677. doi: 10.1016/j.vaccine.2008.09.016
-
(2008)
Vaccine
, vol.26
, pp. 6671-6677
-
-
Guimaraes-Walker, A.1
Mackie, N.2
McCormack, S.3
Hanke, T.4
Schmidt, C.5
Gilmour, J.6
-
114
-
-
0036310564
-
Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins
-
Haglund, K., Leiner, I., Kerksiek, K., Buonocore, L., Pamer, E., and Rose, J. K. (2002). Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins. J. Virol. 76, 7506-7517. doi: 10.1128/JVI.76.15.7506-7517.2002
-
(2002)
J. Virol.
, vol.76
, pp. 7506-7517
-
-
Haglund, K.1
Leiner, I.2
Kerksiek, K.3
Buonocore, L.4
Pamer, E.5
Rose, J.K.6
-
115
-
-
84887865083
-
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine
-
Hammer, S. M., Sobieszczyk, M. E., Janes, H., Karuna, S. T., Mulligan, M. J., Grove, D., et al. (2013). Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N. Engl. J. Med. 369, 2083-2092. doi: 10.1056/NEJMoa1310566
-
(2013)
N. Engl. J. Med.
, vol.369
, pp. 2083-2092
-
-
Hammer, S.M.1
Sobieszczyk, M.E.2
Janes, H.3
Karuna, S.T.4
Mulligan, M.J.5
Grove, D.6
-
116
-
-
79957618772
-
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
-
Hansen, S. G., Ford, J. C., Lewis, M. S., Ventura, A. B., Hughes, C. M., Coyne-Johnson, L., et al. (2011). Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473, 523-527. doi: 10.1038/nature10003
-
(2011)
Nature
, vol.473
, pp. 523-527
-
-
Hansen, S.G.1
Ford, J.C.2
Lewis, M.S.3
Ventura, A.B.4
Hughes, C.M.5
Coyne-Johnson, L.6
-
117
-
-
84885669019
-
Immune clearance of highly pathogenic SIV infection
-
Hansen, S. G., Piatak, M. Jr., Ventura, A. B., Hughes, C. M., Gilbride, R. M., Ford, J. C., et al. (2013). Immune clearance of highly pathogenic SIV infection. Nature 502, 100-104. doi: 10.1038/nature12519
-
(2013)
Nature
, vol.502
, pp. 100-104
-
-
Hansen, S.G.1
Piatak, M.2
Ventura, A.B.3
Hughes, C.M.4
Gilbride, R.M.5
Ford, J.C.6
-
118
-
-
61949216736
-
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
-
Hansen, S. G., Vieville, C., Whizin, N., Coyne-Johnson, L., Siess, D. C., Drummond, D. D., et al. (2009). Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15, 293-299. doi: 10.1038/nm.1935
-
(2009)
Nat. Med.
, vol.15
, pp. 293-299
-
-
Hansen, S.G.1
Vieville, C.2
Whizin, N.3
Coyne-Johnson, L.4
Siess, D.C.5
Drummond, D.D.6
-
119
-
-
38749132973
-
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
-
Harari, A., Bart, P. A., Stohr, W., Tapia, G., Garcia, M., Medjitna-Rais, E., et al. (2008). An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J. Exp. Med. 205, 63-77. doi: 10.1084/jem.20071331
-
(2008)
J. Exp. Med.
, vol.205
, pp. 63-77
-
-
Harari, A.1
Bart, P.A.2
Stohr, W.3
Tapia, G.4
Garcia, M.5
Medjitna-Rais, E.6
-
120
-
-
84868130504
-
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients
-
Harari, A., Rozot, V., Cavassini, M., Enders, F. B., Vigano, S., Tapia, G., et al. (2012). NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients. Eur. J. Immunol. 42, 3038-3048. doi: 10.1002/eji.201242696
-
(2012)
Eur. J. Immunol.
, vol.42
, pp. 3038-3048
-
-
Harari, A.1
Rozot, V.2
Cavassini, M.3
Enders, F.B.4
Vigano, S.5
Tapia, G.6
-
121
-
-
33745223435
-
Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial
-
Harrop, R., Connolly, N., Redchenko, I., Valle, J., Saunders, M., Ryan, M. G., et al. (2006). Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial. Clin. Cancer Res. 12(Pt 1), 3416-3424. doi: 10.1158/1078-0432.CCR-05-2732
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 3416-3424
-
-
Harrop, R.1
Connolly, N.2
Redchenko, I.3
Valle, J.4
Saunders, M.5
Ryan, M.G.6
-
122
-
-
78649589557
-
Robust genital gag-specific CD8+ T-cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV-1-gag
-
Haut, L. H., Lin, S. W., Tatsis, N., DiMenna, L. J., Giles-Davis, W., Pinto, A. R., et al. (2010). Robust genital gag-specific CD8+ T-cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV-1-gag. Eur. J. Immunol. 40, 3426-3438. doi: 10.1002/eji.201040440
-
(2010)
Eur. J. Immunol.
, vol.40
, pp. 3426-3438
-
-
Haut, L.H.1
Lin, S.W.2
Tatsis, N.3
DiMenna, L.J.4
Giles-Davis, W.5
Pinto, A.R.6
-
123
-
-
0034712873
-
Viral recombinant vaccines to the E6 and E7 antigens of HPV-16
-
He, Z., Wlazlo, A. P., Kowalczyk, D. W., Cheng, J., Xiang, Z. Q., Giles-Davis, W., et al. (2000). Viral recombinant vaccines to the E6 and E7 antigens of HPV-16. Virology 270, 146-161. doi: 10.1006/viro.2000.0271
-
(2000)
Virology
, vol.270
, pp. 146-161
-
-
He, Z.1
Wlazlo, A.P.2
Kowalczyk, D.W.3
Cheng, J.4
Xiang, Z.Q.5
Giles-Davis, W.6
-
125
-
-
79952414942
-
Global trends in molecular epidemiology of HIV-1 during 2000-2007
-
Hemelaar, J., Gouws, E., Ghys, P. D., Osmanov, S., and Isolation W-UNfH, Characterisation. (2011). Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25, 679-689. doi: 10.1097/QAD.0b013e328342ff93
-
(2011)
AIDS
, vol.25
, pp. 679-689
-
-
Hemelaar, J.1
Gouws, E.2
Ghys, P.D.3
Osmanov, S.4
-
126
-
-
27144508046
-
Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors
-
Hensley, S. E., Giles-Davis, W., McCoy, K. C., Weninger, W., and Ertl, H. C. (2005). Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors. J. Immunol. 175, 6032-6041. doi: 10.4049/jimmunol.175.9.6032
-
(2005)
J. Immunol.
, vol.175
, pp. 6032-6041
-
-
Hensley, S.E.1
Giles-Davis, W.2
McCoy, K.C.3
Weninger, W.4
Ertl, H.C.5
-
127
-
-
74949098813
-
Prime-boost vectored malaria vaccines: progress and prospects
-
Hill, A. V., Reyes-Sandoval, A., O'Hara, G., Ewer, K., Lawrie, A., Goodman, A., et al. (2010). Prime-boost vectored malaria vaccines: progress and prospects. Hum. Vaccin. 6, 78-83. doi: 10.4161/hv.6.1.10116
-
(2010)
Hum. Vaccin.
, vol.6
, pp. 78-83
-
-
Hill, A.V.1
Reyes-Sandoval, A.2
O'Hara, G.3
Ewer, K.4
Lawrie, A.5
Goodman, A.6
-
128
-
-
84875257547
-
History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system
-
Hoke, C. H. Jr., and Snyder, C. E. Jr. (2013). History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system. Vaccine 31, 1623-1632. doi: 10.1016/j.vaccine.2012.12.029
-
(2013)
Vaccine
, vol.31
, pp. 1623-1632
-
-
Hoke, C.H.1
Snyder, C.E.2
-
129
-
-
17644371966
-
Mucosal immunity and vaccines
-
Holmgren, J., and Czerkinsky, C. (2005). Mucosal immunity and vaccines. Nat. Med. 11, S45-53. doi: 10.1038/nm1213
-
(2005)
Nat. Med.
, vol.11
, pp. S45-53
-
-
Holmgren, J.1
Czerkinsky, C.2
-
130
-
-
0038325751
-
Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges
-
Holmgren, J., Czerkinsky, C., Eriksson, K., and Mharandi, A. (2003). Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 21(Suppl. 2), S89-S95. doi: 10.1016/S0264-410X(03)00206-8
-
(2003)
Vaccine
, vol.21
, pp. S89-S95
-
-
Holmgren, J.1
Czerkinsky, C.2
Eriksson, K.3
Mharandi, A.4
-
131
-
-
8644281993
-
Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5
-
Holterman, L., Vogels, R., van der Vlugt, R., Sieuwerts, M., Grimbergen, J., Kaspers, J., et al. (2004). Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5. J. Virol. 78, 13207-13215. doi: 10.1128/JVI.78.23.13207-13215.2004
-
(2004)
J. Virol.
, vol.78
, pp. 13207-13215
-
-
Holterman, L.1
Vogels, R.2
van der Vlugt, R.3
Sieuwerts, M.4
Grimbergen, J.5
Kaspers, J.6
-
132
-
-
82255164205
-
Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors
-
Hopkins, R., Bridgeman, A., Bourne, C., Mbewe-Mvula, A., Sadoff, J. C., Both, G. W., et al. (2011a). Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors. Eur. J. Immunol. 41, 3542-3552. doi: 10.1002/eji.201141962
-
(2011)
Eur. J. Immunol.
, vol.41
, pp. 3542-3552
-
-
Hopkins, R.1
Bridgeman, A.2
Bourne, C.3
Mbewe-Mvula, A.4
Sadoff, J.C.5
Both, G.W.6
-
133
-
-
79955939284
-
Dual neonate vaccine platform against HIV-1 and M. tuberculosis
-
Hopkins, R., Bridgeman, A., Joseph, J., Gilbert, S. C., McShane, H., and Hanke, T., (2011b). Dual neonate vaccine platform against HIV-1 and M. tuberculosis. PLoS ONE 6:e20067. doi: 10.1371/journal.pone.0020067
-
(2011)
PLoS ONE
, vol.6
-
-
Hopkins, R.1
Bridgeman, A.2
Joseph, J.3
Gilbert, S.C.4
McShane, H.5
Hanke, T.6
-
134
-
-
0035423454
-
Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites
-
Horner, A. A., Datta, S. K., Takabayashi, K., Belyakov, I. M., Hayashi, T., Cinman, N., et al. (2001). Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites. J. Immunol. 167, 1584-1591. doi: 10.4049/jimmunol.167.3.1584
-
(2001)
J. Immunol.
, vol.167
, pp. 1584-1591
-
-
Horner, A.A.1
Datta, S.K.2
Takabayashi, K.3
Belyakov, I.M.4
Hayashi, T.5
Cinman, N.6
-
135
-
-
77957752730
-
Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects
-
Howles, S., Guimaraes-Walker, A., Yang, H., Hancock, G., di Gleria, K., Tarragona-Fiol, T., et al. (2010). Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects. Vaccine 28, 7306-7312. doi: 10.1016/j.vaccine.2010.08.077
-
(2010)
Vaccine
, vol.28
, pp. 7306-7312
-
-
Howles, S.1
Guimaraes-Walker, A.2
Yang, H.3
Hancock, G.4
di Gleria, K.5
Tarragona-Fiol, T.6
-
136
-
-
84881444344
-
CCL19 and CCL28 augment mucosal and systemic immune responses to HIV-1 gp140 by mobilizing responsive immunocytes into secondary lymph nodes and mucosal tissue
-
Hu, K., Luo, S., Tong, L., Huang, X., Jin, W., Huang, W., et al. (2013). CCL19 and CCL28 augment mucosal and systemic immune responses to HIV-1 gp140 by mobilizing responsive immunocytes into secondary lymph nodes and mucosal tissue. J. Immunol. 191, 1935-1947. doi: 10.4049/jimmunol.1300120
-
(2013)
J. Immunol.
, vol.191
, pp. 1935-1947
-
-
Hu, K.1
Luo, S.2
Tong, L.3
Huang, X.4
Jin, W.5
Huang, W.6
-
137
-
-
33745345216
-
Unidirectional development of CD8+ central memory T cells into protective Listeria-specific effector memory T cells
-
Huster, K. M., Koffler, M., Stemberger, C., Schiemann, M., Wagner, H., and Busch, D. H. (2006). Unidirectional development of CD8+ central memory T cells into protective Listeria-specific effector memory T cells. Eur. J. Immunol. 36, 1453-1464. doi: 10.1002/eji.200635874
-
(2006)
Eur. J. Immunol.
, vol.36
, pp. 1453-1464
-
-
Huster, K.M.1
Koffler, M.2
Stemberger, C.3
Schiemann, M.4
Wagner, H.5
Busch, D.H.6
-
138
-
-
78650982702
-
Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality
-
Hutnick, N. A., Carnathan, D. G., Dubey, S. A., Cox, K. S., Kierstead, L., Makadonas, G., et al. (2010). Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality. PLoS ONE 5:e14385. doi: 10.1371/journal.pone.0014385
-
(2010)
PLoS ONE
, vol.5
-
-
Hutnick, N.A.1
Carnathan, D.G.2
Dubey, S.A.3
Cox, K.S.4
Kierstead, L.5
Makadonas, G.6
-
139
-
-
84898716198
-
DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques
-
Jalah, R., Kulkarni, V., Patel, V., Rosati, M., Alicea, C., Bear, J., et al. (2014). DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques. PLoS ONE 9:e91550. doi: 10.1371/journal.pone.0091550
-
(2014)
PLoS ONE
, vol.9
-
-
Jalah, R.1
Kulkarni, V.2
Patel, V.3
Rosati, M.4
Alicea, C.5
Bear, J.6
-
140
-
-
10644238967
-
CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides
-
Jiang, J. Q., Patrick, A., Moss, R. B., and Rosenthal, K. L. (2005). CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides. J. Virol. 79, 393-400. doi: 10.1128/JVI.79.1.393-400.2005
-
(2005)
J. Virol.
, vol.79
, pp. 393-400
-
-
Jiang, J.Q.1
Patrick, A.2
Moss, R.B.3
Rosenthal, K.L.4
-
141
-
-
84855361060
-
Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults
-
Kalams, S. A., Parker, S., Jin, X., Elizaga, M., Metch, B., Wang, M., et al. (2012). Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults. PLoS ONE 7:e29231. doi: 10.1371/journal.pone.0029231
-
(2012)
PLoS ONE
, vol.7
-
-
Kalams, S.A.1
Parker, S.2
Jin, X.3
Elizaga, M.4
Metch, B.5
Wang, M.6
-
142
-
-
84881623207
-
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery
-
Kalams, S. A., Parker, S. D., Elizaga, M., Metch, B., Edupuganti, S., Hural, J., et al. (2013). Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. J. Infect. Dis. 208, 818-829. doi: 10.1093/infdis/jit236
-
(2013)
J. Infect. Dis.
, vol.208
, pp. 818-829
-
-
Kalams, S.A.1
Parker, S.D.2
Elizaga, M.3
Metch, B.4
Edupuganti, S.5
Hural, J.6
-
143
-
-
84894499997
-
Immunogenicity of ALVAC-HIV vCP1521 in infants of HIV-1-infected women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa
-
Kaleebu, P., Njai, H. F., Wang, L., Jones, N., Ssewanyana, I., Richardson, P., et al. (2014). Immunogenicity of ALVAC-HIV vCP1521 in infants of HIV-1-infected women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa. J. Acquir. Immune Defic. Syndr. 65, 268-277. doi: 10.1097/01.qai.0000435600.65845.31
-
(2014)
J. Acquir. Immune Defic. Syndr.
, vol.65
, pp. 268-277
-
-
Kaleebu, P.1
Njai, H.F.2
Wang, L.3
Jones, N.4
Ssewanyana, I.5
Richardson, P.6
-
145
-
-
79951721121
-
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects
-
Keefer, M. C., Frey, S. E., Elizaga, M., Metch, B., De Rosa, S. C., Barroso, P. F., et al. (2011). A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects. Vaccine 29, 1948-1958. doi: 10.1016/j.vaccine.2010.12.104
-
(2011)
Vaccine
, vol.29
, pp. 1948-1958
-
-
Keefer, M.C.1
Frey, S.E.2
Elizaga, M.3
Metch, B.4
De Rosa, S.C.5
Barroso, P.F.6
-
146
-
-
84864542615
-
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults
-
Keefer, M. C., Gilmour, J., Hayes, P., Gill, D., Kopycinski, J., Cheeseman, H., et al. (2012). A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults. PLoS ONE 7:e41936. doi: 10.1371/journal.pone.0041936
-
(2012)
PLoS ONE
, vol.7
-
-
Keefer, M.C.1
Gilmour, J.2
Hayes, P.3
Gill, D.4
Kopycinski, J.5
Cheeseman, H.6
-
147
-
-
48449105674
-
The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers
-
Kennedy, J. S., Co, M., Green, S., Longtine, K., Longtine, J., O'Neill, M. A., et al. (2008). The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers. Vaccine 26, 4420-4424. doi: 10.1016/j.vaccine.2008.05.090
-
(2008)
Vaccine
, vol.26
, pp. 4420-4424
-
-
Kennedy, J.S.1
Co, M.2
Green, S.3
Longtine, K.4
Longtine, J.5
O'Neill, M.A.6
-
148
-
-
0031772993
-
Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
-
Kent, S. J., Zhao, A., Best, S. J., Chandler, J. D., Boyle, D. B., and Ramshaw, I. A. (1998). Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72, 10180-10188.
-
(1998)
J. Virol.
, vol.72
, pp. 10180-10188
-
-
Kent, S.J.1
Zhao, A.2
Best, S.J.3
Chandler, J.D.4
Boyle, D.B.5
Ramshaw, I.A.6
-
149
-
-
80655128531
-
Improved NYVAC-based vaccine vectors
-
Kibler, K. V., Gomez, C. E., Perdiguero, B., Wong, S., Huynh, T., Holechek, S., et al. (2011). Improved NYVAC-based vaccine vectors. PLoS ONE 6:e25674. doi: 10.1371/journal.pone.0025674
-
(2011)
PLoS ONE
, vol.6
-
-
Kibler, K.V.1
Gomez, C.E.2
Perdiguero, B.3
Wong, S.4
Huynh, T.5
Holechek, S.6
-
150
-
-
77953499055
-
Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection
-
Kim, T. S., Hufford, M. M., Sun, J., Fu, Y. X., and Braciale, T. J. (2010). Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J. Exp. Med. 207, 1161-1172. doi: 10.1084/jem.20092017
-
(2010)
J. Exp. Med.
, vol.207
, pp. 1161-1172
-
-
Kim, T.S.1
Hufford, M.M.2
Sun, J.3
Fu, Y.X.4
Braciale, T.J.5
-
151
-
-
84876280934
-
Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa
-
Kintu, K., Andrew, P., Musoke, P., Richardson, P., Asiimwe-Kateera, B., Nakyanzi, T., et al. (2013). Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa. J. Acquir. Immune Defic. Syndr. 63, 1-8. doi: 10.1097/QAI.0b013e31827f1c2d
-
(2013)
J. Acquir. Immune Defic. Syndr.
, vol.63
, pp. 1-8
-
-
Kintu, K.1
Andrew, P.2
Musoke, P.3
Richardson, P.4
Asiimwe-Kateera, B.5
Nakyanzi, T.6
-
152
-
-
4544258068
-
NALT- versus Peyer's-patch-mediated mucosal immunity
-
Kiyono, H., and Fukuyama, S. (2004). NALT- versus Peyer's-patch-mediated mucosal immunity. Nat. Rev. Immunol. 4, 699-710. doi: 10.1038/nri1439
-
(2004)
Nat. Rev. Immunol.
, vol.4
, pp. 699-710
-
-
Kiyono, H.1
Fukuyama, S.2
-
153
-
-
60049098638
-
Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination
-
Kong, W. P., Wu, L., Wallstrom, T. C., Fischer, W., Yang, Z. Y., Ko, S. Y., et al. (2009). Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination. J. Virol. 83, 2201-2215. doi: 10.1128/JVI.02256-08
-
(2009)
J. Virol.
, vol.83
, pp. 2201-2215
-
-
Kong, W.P.1
Wu, L.2
Wallstrom, T.C.3
Fischer, W.4
Yang, Z.Y.5
Ko, S.Y.6
-
155
-
-
69249211230
-
T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces
-
Korber, B. T., Letvin, N. L., and Haynes, B. F. (2009). T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces. J. Virol. 83, 8300-8314. doi: 10.1128/JVI.00114-09
-
(2009)
J. Virol.
, vol.83
, pp. 8300-8314
-
-
Korber, B.T.1
Letvin, N.L.2
Haynes, B.F.3
-
156
-
-
29044437033
-
Protective immunity and lack of histopathological damage two years after DNA vaccination against infectious hematopoietic necrosis virus in trout
-
Kurath, G., Garver, K. A., Corbeil, S., Elliott, D. G., Anderson, E. D., and LaPatra, S. E. (2006). Protective immunity and lack of histopathological damage two years after DNA vaccination against infectious hematopoietic necrosis virus in trout. Vaccine 24, 345-354. doi: 10.1016/j.vaccine.2005.07.068
-
(2006)
Vaccine
, vol.24
, pp. 345-354
-
-
Kurath, G.1
Garver, K.A.2
Corbeil, S.3
Elliott, D.G.4
Anderson, E.D.5
LaPatra, S.E.6
-
157
-
-
79957947384
-
Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine
-
Lai, L., Kwa, S., Kozlowski, P. A., Montefiori, D. C., Ferrari, G., Johnson, W. E., et al. (2011). Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine. J. Infect. Dis. 204, 164-173. doi: 10.1093/infdis/jir199
-
(2011)
J. Infect. Dis.
, vol.204
, pp. 164-173
-
-
Lai, L.1
Kwa, S.2
Kozlowski, P.A.3
Montefiori, D.C.4
Ferrari, G.5
Johnson, W.E.6
-
158
-
-
68249099660
-
New insights on adenovirus as vaccine vectors
-
Lasaro, M. O., and Ertl, H. C. (2009). New insights on adenovirus as vaccine vectors. Mol. Ther. 17, 1333-1339. doi: 10.1038/mt.2009.130
-
(2009)
Mol. Ther.
, vol.17
, pp. 1333-1339
-
-
Lasaro, M.O.1
Ertl, H.C.2
-
159
-
-
84874274760
-
Randomized phase I: safety, immunogenicity and mucosal antiviral activity in young healthy women vaccinated with HIV-1 Gp41 P1 peptide on virosomes
-
Leroux-Roels, G., Maes, C., Clement, F., van Engelenburg, F., van den Dobbelsteen, M., Adler, M., et al. (2013). Randomized phase I: safety, immunogenicity and mucosal antiviral activity in young healthy women vaccinated with HIV-1 Gp41 P1 peptide on virosomes. PLoS ONE 8:e55438. doi: 10.1371/journal.pone.0055438
-
(2013)
PLoS ONE
, vol.8
-
-
Leroux-Roels, G.1
Maes, C.2
Clement, F.3
van Engelenburg, F.4
van den Dobbelsteen, M.5
Adler, M.6
-
160
-
-
41549136952
-
Design and pre-clinical evaluation of a universal HIV-1 vaccine
-
Letourneau, S., Im, E. J., Mashishi, T., Brereton, C., Bridgeman, A., Yang, H., et al. (2007). Design and pre-clinical evaluation of a universal HIV-1 vaccine. PLoS ONE 2:e984. doi: 10.1371/journal.pone.0000984
-
(2007)
PLoS ONE
, vol.2
-
-
Letourneau, S.1
Im, E.J.2
Mashishi, T.3
Brereton, C.4
Bridgeman, A.5
Yang, H.6
-
161
-
-
84877700482
-
Engineering influenza viral vectors
-
Li, J., Arevalo, M. T., and Zeng, M. (2013). Engineering influenza viral vectors. Bioengineered 4, 9-14. doi: 10.4161/bioe.21950
-
(2013)
Bioengineered
, vol.4
, pp. 9-14
-
-
Li, J.1
Arevalo, M.T.2
Zeng, M.3
-
162
-
-
0027494094
-
Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1
-
Li, S., Polonis, V., Isobe, H., Zaghouani, H., Guinea, R., Moran, T., et al. (1993a). Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1. J. Virol. 67, 6659-6666.
-
(1993)
J. Virol.
, vol.67
, pp. 6659-6666
-
-
Li, S.1
Polonis, V.2
Isobe, H.3
Zaghouani, H.4
Guinea, R.5
Moran, T.6
-
163
-
-
0027292880
-
Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria
-
Li, S., Rodrigues, M., Rodriguez, D., Rodriguez, J. R., Esteban, M., Palese, P., et al. (1993b). Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc. Natl. Acad. Sci. U.S.A. 90, 5214-5218.
-
(1993)
Proc. Natl. Acad. Sci. U.S.A.
, vol.90
, pp. 5214-5218
-
-
Li, S.1
Rodrigues, M.2
Rodriguez, D.3
Rodriguez, J.R.4
Esteban, M.5
Palese, P.6
-
164
-
-
84857065444
-
Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection
-
Lietz, R., Bayer, W., Ontikatze, T., Johrden, L., Tenbusch, M., Storcksdieck Genannt Bonsmann, M., et al. (2012). Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection. J. Virol. 86, 1706-1716. doi: 10.1128/JVI.06244-11
-
(2012)
J. Virol.
, vol.86
, pp. 1706-1716
-
-
Lietz, R.1
Bayer, W.2
Ontikatze, T.3
Johrden, L.4
Tenbusch, M.5
Storcksdieck Genannt Bonsmann, M.6
-
165
-
-
84862219175
-
Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans
-
Lillie, P. J., Berthoud, T. K., Powell, T. J., Lambe, T., Mullarkey, C., Spencer, A. J., et al. (2012). Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans. Clin. Infect. Dis. 55, 19-25. doi: 10.1093/cid/cis327
-
(2012)
Clin. Infect. Dis.
, vol.55
, pp. 19-25
-
-
Lillie, P.J.1
Berthoud, T.K.2
Powell, T.J.3
Lambe, T.4
Mullarkey, C.5
Spencer, A.J.6
-
166
-
-
84878808107
-
Immunogenicity analysis following human immunodeficiency virus recombinant DNA and recombinant vaccinia virus Tian Tan prime-boost immunization
-
Liu, C., Du, S., Li, C., Wang, Y., Wang, M., Li, Y., et al. (2013). Immunogenicity analysis following human immunodeficiency virus recombinant DNA and recombinant vaccinia virus Tian Tan prime-boost immunization. Sci. China Life Sci. 56, 531-540. doi: 10.1007/s11427-013-4484-2
-
(2013)
Sci. China Life Sci.
, vol.56
, pp. 531-540
-
-
Liu, C.1
Du, S.2
Li, C.3
Wang, Y.4
Wang, M.5
Li, Y.6
-
167
-
-
58149267963
-
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
-
Liu, J., O'Brien, K. L., Lynch, D. M., Simmons, N. L., La Porte, A., Riggs, A. M., et al. (2009). Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457, 87-91. doi: 10.1038/nature07469
-
(2009)
Nature
, vol.457
, pp. 87-91
-
-
Liu, J.1
O'Brien, K.L.2
Lynch, D.M.3
Simmons, N.L.4
La Porte, A.5
Riggs, A.M.6
-
168
-
-
84899076595
-
Circumventing antivector immunity: potential use of nonhuman adenoviral vectors
-
Lopez-Gordo, E., Podgorski, I. I., Downes, N., and Alemany, R. (2014). Circumventing antivector immunity: potential use of nonhuman adenoviral vectors. Hum. Gene Ther. 25, 285-300. doi: 10.1089/hum.2013.228
-
(2014)
Hum. Gene Ther.
, vol.25
, pp. 285-300
-
-
Lopez-Gordo, E.1
Podgorski, I.I.2
Downes, N.3
Alemany, R.4
-
169
-
-
61849122809
-
Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes
-
Luo, X. M., Maarschalk, E., O'Connell, R. M., Wang, P., Yang, L., and Baltimore, D. (2009). Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes. Blood 113, 1422-1431. doi: 10.1182/blood-2008-09-177139
-
(2009)
Blood
, vol.113
, pp. 1422-1431
-
-
Luo, X.M.1
Maarschalk, E.2
O'Connell, R.M.3
Wang, P.4
Yang, L.5
Baltimore, D.6
-
170
-
-
0028488883
-
[Experiences with immunization against orthopox viruses of humans and animals using vaccine strain MVA]
-
Mahnel, H., and Mayr, A. (1994). [Experiences with immunization against orthopox viruses of humans and animals using vaccine strain MVA]. Berl. Munch. Tierarztl. Wochenschr. 107, 253-256.
-
(1994)
Berl. Munch. Tierarztl. Wochenschr.
, vol.107
, pp. 253-256
-
-
Mahnel, H.1
Mayr, A.2
-
171
-
-
4043123993
-
Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen
-
Makitalo, B., Lundholm, P., Hinkula, J., Nilsson, C., Karlen, K., Morner, A., et al. (2004). Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen. J. Gen. Virol. 85(Pt 8), 2407-2419. doi: 10.1099/vir.0.79869-0
-
(2004)
J. Gen. Virol.
, vol.85
, pp. 2407-2419
-
-
Makitalo, B.1
Lundholm, P.2
Hinkula, J.3
Nilsson, C.4
Karlen, K.5
Morner, A.6
-
172
-
-
84901312972
-
Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes
-
Mann, J. F., McKay, P. F., Fiserova, A., Klein, K., Cope, A., Rogers, P., et al. (2014). Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes. J. Virol. 88, 6959-6969. doi: 10.1128/JVI.00183-14
-
(2014)
J. Virol.
, vol.88
, pp. 6959-6969
-
-
Mann, J.F.1
McKay, P.F.2
Fiserova, A.3
Klein, K.4
Cope, A.5
Rogers, P.6
-
173
-
-
33745810216
-
Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination
-
Masopust, D., Ha, S. J., Vezys, V., and Ahmed, R. (2006). Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J. Immunol. 177, 831-839. doi: 10.4049/jimmunol.177.2.831
-
(2006)
J. Immunol.
, vol.177
, pp. 831-839
-
-
Masopust, D.1
Ha, S.J.2
Vezys, V.3
Ahmed, R.4
-
174
-
-
0035937587
-
Preferential localization of effector memory cells in nonlymphoid tissue
-
Masopust, D., Vezys, V., Marzo, A. L., and Lefrancois, L. (2001). Preferential localization of effector memory cells in nonlymphoid tissue. Science 291, 2413-2417. doi: 10.1126/science.1058867
-
(2001)
Science
, vol.291
, pp. 2413-2417
-
-
Masopust, D.1
Vezys, V.2
Marzo, A.L.3
Lefrancois, L.4
-
175
-
-
73949160519
-
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials
-
Mast, T. C., Kierstead, L., Gupta, S. B., Nikas, A. A., Kallas, E. G., Novitsky, V., et al. (2010). International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. Vaccine 28, 950-957. doi: 10.1016/j.vaccine.2009.10.145
-
(2010)
Vaccine
, vol.28
, pp. 950-957
-
-
Mast, T.C.1
Kierstead, L.2
Gupta, S.B.3
Nikas, A.A.4
Kallas, E.G.5
Novitsky, V.6
-
176
-
-
0035172551
-
4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen
-
4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen. J. Virol. 75, 11891-11896. doi: 10.1128/JVI.75.23.11891-118l96.2001
-
(2001)
J. Virol.
, vol.75
, pp. 11891-11896
-
-
Matano, T.1
Kano, M.2
Nakamura, H.3
Takeda, A.4
Nagai, Y.5
-
177
-
-
79551634103
-
Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice
-
Mazumder, S., Maji, M., Das, A., and Ali, N. (2011). Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice. PLoS ONE 6:e14644. doi: 10.1371/journal.pone.0014644
-
(2011)
PLoS ONE
, vol.6
-
-
Mazumder, S.1
Maji, M.2
Das, A.3
Ali, N.4
-
178
-
-
0038714287
-
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
-
McConkey, S. J., Reece, W. H., Moorthy, V. S., Webster, D., Dunachie, S., Butcher, G., et al. (2003). Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat. Med. 9, 729-735. doi: 10.1038/nm881
-
(2003)
Nat. Med.
, vol.9
, pp. 729-735
-
-
McConkey, S.J.1
Reece, W.H.2
Moorthy, V.S.3
Webster, D.4
Dunachie, S.5
Butcher, G.6
-
179
-
-
44749088148
-
EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
-
McCormack, S., Stohr, W., Barber, T., Bart, P. A., Harari, A., Moog, C., et al. (2008). EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone. Vaccine 26, 3162-3174. doi: 10.1016/j.vaccine.2008.02.072
-
(2008)
Vaccine
, vol.26
, pp. 3162-3174
-
-
McCormack, S.1
Stohr, W.2
Barber, T.3
Bart, P.A.4
Harari, A.5
Moog, C.6
-
180
-
-
34249930119
-
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors
-
McCoy, K., Tatsis, N., Korioth-Schmitz, B., Lasaro, M. O., Hensley, S. E., Lin, S. W., et al. (2007). Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors. J. Virol. 81, 6594-6604. doi: 10.1128/JVI.02497-06
-
(2007)
J. Virol.
, vol.81
, pp. 6594-6604
-
-
McCoy, K.1
Tatsis, N.2
Korioth-Schmitz, B.3
Lasaro, M.O.4
Hensley, S.E.5
Lin, S.W.6
-
181
-
-
56649114351
-
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
-
McElrath, M. J., De Rosa, S. C., Moodie, Z., Dubey, S., Kierstead, L., Janes, H., et al. (2008). HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372, 1894-1905. doi: 10.1016/S0140-6736(08)61592-5
-
(2008)
Lancet
, vol.372
, pp. 1894-1905
-
-
McElrath, M.J.1
De Rosa, S.C.2
Moodie, Z.3
Dubey, S.4
Kierstead, L.5
Janes, H.6
-
182
-
-
84899877379
-
Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen
-
McKay, P. F., Cope, A. V., Mann, J. F., Joseph, S., Esteban, M., Tatoud, R., et al. (2014). Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen. PLoS ONE 9:e84707. doi: 10.1371/journal.pone.0084707
-
(2014)
PLoS ONE
, vol.9
-
-
McKay, P.F.1
Cope, A.V.2
Mann, J.F.3
Joseph, S.4
Esteban, M.5
Tatoud, R.6
-
183
-
-
33646172660
-
HIV vaccines
-
McMichael, A. J. (2006). HIV vaccines. Annu. Rev. Immunol. 24, 227-255. doi: 10.1146/annurev.immunol.24.021605.090605
-
(2006)
Annu. Rev. Immunol.
, vol.24
, pp. 227-255
-
-
McMichael, A.J.1
-
184
-
-
0036085692
-
Prime-boost immunization strategies for infectious diseases
-
McShane, H. (2002). Prime-boost immunization strategies for infectious diseases. Curr. Opin. Mol. Ther. 4, 23-27.
-
(2002)
Curr. Opin. Mol. Ther.
, vol.4
, pp. 23-27
-
-
McShane, H.1
-
186
-
-
0025876805
-
Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence
-
Meyer, H., Sutter, G., and Mayr, A. (1991). Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 72(Pt 5), 1031-1038.
-
(1991)
J. Gen. Virol.
, vol.72
, pp. 1031-1038
-
-
Meyer, H.1
Sutter, G.2
Mayr, A.3
-
187
-
-
40149094782
-
4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates
-
4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates. J. Virol. 82, 2975-2988. doi: 10.1128/JVI.02216-07
-
(2008)
J. Virol.
, vol.82
, pp. 2975-2988
-
-
Mooij, P.1
Balla-Jhagjhoorsingh, S.S.2
Koopman, G.3
Beenhakker, N.4
van Haaften, P.5
Baak, I.6
-
188
-
-
35348998498
-
Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations
-
Moser, C., Amacker, M., Kammer, A. R., Rasi, S., Westerfeld, N., and Zurbriggen, R. (2007). Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations. Expert Rev. Vaccines 6, 711-721. doi: 10.1586/14760584.6.5.711
-
(2007)
Expert Rev. Vaccines
, vol.6
, pp. 711-721
-
-
Moser, C.1
Amacker, M.2
Kammer, A.R.3
Rasi, S.4
Westerfeld, N.5
Zurbriggen, R.6
-
189
-
-
40449097257
-
The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response
-
Muruve, D. A., Petrilli, V., Zaiss, A. K., White, L. R., Clark, S. A., Ross, P. J., et al. (2008). The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452, 103-107. doi: 10.1038/nature06664
-
(2008)
Nature
, vol.452
, pp. 103-107
-
-
Muruve, D.A.1
Petrilli, V.2
Zaiss, A.K.3
White, L.R.4
Clark, S.A.5
Ross, P.J.6
-
190
-
-
0028853959
-
Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus
-
Muster, T., Ferko, B., Klima, A., Purtscher, M., Trkola, A., Schulz, P., et al. (1995). Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J. Virol. 69, 6678-6686.
-
(1995)
J. Virol.
, vol.69
, pp. 6678-6686
-
-
Muster, T.1
Ferko, B.2
Klima, A.3
Purtscher, M.4
Trkola, A.5
Schulz, P.6
-
191
-
-
0028235930
-
Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS
-
Muster, T., Guinea, R., Trkola, A., Purtscher, M., Klima, A., Steindl, F., et al. (1994). Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS. J. Virol. 68, 4031-4034.
-
(1994)
J. Virol.
, vol.68
, pp. 4031-4034
-
-
Muster, T.1
Guinea, R.2
Trkola, A.3
Purtscher, M.4
Klima, A.5
Steindl, F.6
-
192
-
-
0027378573
-
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
-
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., et al. (1993). A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67, 6642-6647.
-
(1993)
J. Virol.
, vol.67
, pp. 6642-6647
-
-
Muster, T.1
Steindl, F.2
Purtscher, M.3
Trkola, A.4
Klima, A.5
Himmler, G.6
-
193
-
-
11144355460
-
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans
-
Mwau, M., Cebere, I., Sutton, J., Chikoti, P., Winstone, N., Wee, E. G., et al. (2004). A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J. Gen. Virol. 85, 911-919. doi: 10.1099/vir.0.19701-0
-
(2004)
J. Gen. Virol.
, vol.85
, pp. 911-919
-
-
Mwau, M.1
Cebere, I.2
Sutton, J.3
Chikoti, P.4
Winstone, N.5
Wee, E.G.6
-
194
-
-
27344443419
-
Innate immune response to adenovirus
-
Nazir, S. A., and Metcalf, J. P. (2005). Innate immune response to adenovirus. J. Investig. Med. 53, 292-304. doi: 10.2310/6650.2005.53605
-
(2005)
J. Investig. Med.
, vol.53
, pp. 292-304
-
-
Nazir, S.A.1
Metcalf, J.P.2
-
195
-
-
0036229959
-
Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses
-
Newman, M. J. (2002). Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses. Curr. Opin. Investig. Drugs 3, 374-378.
-
(2002)
Curr. Opin. Investig. Drugs
, vol.3
, pp. 374-378
-
-
Newman, M.J.1
-
196
-
-
80053592167
-
Strategies and implications for prime-boost vaccination to generate memory CD8 T cells
-
Nolz, J. C., and Harty, J. T. (2011). Strategies and implications for prime-boost vaccination to generate memory CD8 T cells. Adv. Exp. Med. Biol. 780:69-83. doi: 10.1007/978-1-4419-5632-3_7
-
(2011)
Adv. Exp. Med. Biol.
, vol.780
, pp. 69-83
-
-
Nolz, J.C.1
Harty, J.T.2
-
197
-
-
84856880087
-
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector
-
O'Hara, G. A., Duncan, C. J., Ewer, K. J., Collins, K. A., Elias, S. C., Halstead, F. D., et al. (2012). Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector. J. Infect. Dis. 205, 772-781. doi: 10.1093/infdis/jir850
-
(2012)
J. Infect. Dis.
, vol.205
, pp. 772-781
-
-
O'Hara, G.A.1
Duncan, C.J.2
Ewer, K.J.3
Collins, K.A.4
Elias, S.C.5
Halstead, F.D.6
-
198
-
-
84891784029
-
Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection
-
Ohs, I., Windmann, S., Wildner, O., Dittmer, U., and Bayer, W. (2013). Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection. PLoS ONE 8:e82528. doi: 10.1371/journal.pone.0082528
-
(2013)
PLoS ONE
, vol.8
-
-
Ohs, I.1
Windmann, S.2
Wildner, O.3
Dittmer, U.4
Bayer, W.5
-
201
-
-
0030745787
-
Development of novel influenza virus vaccines and vectors
-
Palese, P., Zavala, F., Muster, T., Nussenzweig, R. S., and Garcia-Sastre, A. (1997). Development of novel influenza virus vaccines and vectors. J. Infect. Dis. 176(Suppl. 1), S45-S49.
-
(1997)
J. Infect. Dis.
, vol.176
, pp. S45-S49
-
-
Palese, P.1
Zavala, F.2
Muster, T.3
Nussenzweig, R.S.4
Garcia-Sastre, A.5
-
202
-
-
84874232605
-
DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge
-
Patel, V., Jalah, R., Kulkarni, V., Valentin, A., Rosati, M., Alicea, C., et al. (2013). DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge. Proc. Natl. Acad. Sci. U.S.A. 110, 2975-2980. doi: 10.1073/pnas.1215393110
-
(2013)
Proc. Natl. Acad. Sci. U.S.A.
, vol.110
, pp. 2975-2980
-
-
Patel, V.1
Jalah, R.2
Kulkarni, V.3
Valentin, A.4
Rosati, M.5
Alicea, C.6
-
203
-
-
77954218164
-
Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization
-
Patel, V., Valentin, A., Kulkarni, V., Rosati, M., Bergamaschi, C., Jalah, R., et al. (2010). Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine 28, 4827-4836. doi: 10.1016/j.vaccine.2010.04.064
-
(2010)
Vaccine
, vol.28
, pp. 4827-4836
-
-
Patel, V.1
Valentin, A.2
Kulkarni, V.3
Rosati, M.4
Bergamaschi, C.5
Jalah, R.6
-
204
-
-
52949116799
-
Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development
-
Patterson, L. J., and Robert-Guroff, M. (2008). Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development. Expert Opin. Biol. Ther. 8, 1347-1363. doi: 10.1517/14712598.8.9.1347
-
(2008)
Expert Opin. Biol. Ther.
, vol.8
, pp. 1347-1363
-
-
Patterson, L.J.1
Robert-Guroff, M.2
-
205
-
-
58149293629
-
Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells
-
Perreau, M., Pantaleo, G., and Kremer, E. J. (2008). Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells. J. Exp. Med. 205, 2717-2725. doi: 10.1084/jem.20081786
-
(2008)
J. Exp. Med.
, vol.205
, pp. 2717-2725
-
-
Perreau, M.1
Pantaleo, G.2
Kremer, E.J.3
-
206
-
-
66149084072
-
Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo
-
Pichla-Gollon, S. L., Lin, S. W., Hensley, S. E., Lasaro, M. O., Herkenhoff-Haut, L., Drinker, M., et al. (2009). Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo. J. Virol. 83, 5567-5573. doi: 10.1128/JVI.00405-09
-
(2009)
J. Virol.
, vol.83
, pp. 5567-5573
-
-
Pichla-Gollon, S.L.1
Lin, S.W.2
Hensley, S.E.3
Lasaro, M.O.4
Herkenhoff-Haut, L.5
Drinker, M.6
-
207
-
-
33845433434
-
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
-
Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., et al. (2006). Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infect. Dis. 194, 1661-1671. doi: 10.1086/508748
-
(2006)
J. Infect. Dis.
, vol.194
, pp. 1661-1671
-
-
Pitisuttithum, P.1
Gilbert, P.2
Gurwith, M.3
Heyward, W.4
Martin, M.5
van Griensven, F.6
-
208
-
-
84882922175
-
Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling
-
Price, P. J., Torres-Dominguez, L. E., Brandmuller, C., Sutter, G., and Lehmann, M. H. (2013). Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling. Vaccine 31, 4231-4234. doi: 10.1016/j.vaccine.2013.03.017
-
(2013)
Vaccine
, vol.31
, pp. 4231-4234
-
-
Price, P.J.1
Torres-Dominguez, L.E.2
Brandmuller, C.3
Sutter, G.4
Lehmann, M.H.5
-
209
-
-
84857207064
-
Foreskin T-cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile, and memory status
-
Prodger, J. L., Gray, R., Kigozi, G., Nalugoda, F., Galiwango, R., Hirbod, T., et al. (2012). Foreskin T-cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile, and memory status. Mucosal Immunol. 5, 121-128. doi: 10.1038/mi.2011.56
-
(2012)
Mucosal Immunol.
, vol.5
, pp. 121-128
-
-
Prodger, J.L.1
Gray, R.2
Kigozi, G.3
Nalugoda, F.4
Galiwango, R.5
Hirbod, T.6
-
210
-
-
84863116109
-
Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine
-
Qureshi, H., Ma, Z. M., Huang, Y., Hodge, G., Thomas, M. A., DiPasquale, J., et al. (2012). Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine. J. Virol. 86, 2239-2250. doi: 10.1128/JVI.06175-11
-
(2012)
J. Virol.
, vol.86
, pp. 2239-2250
-
-
Qureshi, H.1
Ma, Z.M.2
Huang, Y.3
Hodge, G.4
Thomas, M.A.5
DiPasquale, J.6
-
211
-
-
0034176364
-
The prime-boost strategy: exciting prospects for improved vaccination
-
Ramshaw, I. A., and Ramsay, A. J. (2000). The prime-boost strategy: exciting prospects for improved vaccination. Immunol. Today 21, 163-165. doi: 10.1016/S0167-5699(00)01612-1
-
(2000)
Immunol. Today
, vol.21
, pp. 163-165
-
-
Ramshaw, I.A.1
Ramsay, A.J.2
-
212
-
-
33846924548
-
Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles
-
Ranasinghe, C., Turner, S. J., McArthur, C., Sutherland, D. B., Kim, J. H., Doherty, P. C., et al. (2007). Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles. J. Immunol. 178, 2370-2379. doi: 10.4049/jimmunol.178.4.2370
-
(2007)
J. Immunol.
, vol.178
, pp. 2370-2379
-
-
Ranasinghe, C.1
Turner, S.J.2
McArthur, C.3
Sutherland, D.B.4
Kim, J.H.5
Doherty, P.C.6
-
213
-
-
84866858197
-
Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens
-
Ratto-Kim, S., Currier, J. R., Cox, J. H., Excler, J. L., Valencia-Micolta, A., Thelian, D., et al. (2012). Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens. PLoS ONE 7:e45840. doi: 10.1371/journal.pone.0045840
-
(2012)
PLoS ONE
, vol.7
-
-
Ratto-Kim, S.1
Currier, J.R.2
Cox, J.H.3
Excler, J.L.4
Valencia-Micolta, A.5
Thelian, D.6
-
214
-
-
84875579579
-
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E
-
Rerks-Ngarm, S., Paris, R. M., Chunsutthiwat, S., Premsri, N., Namwat, C., Bowonwatanuwong, C., et al. (2013). Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E. J. Infect. Dis. 207, 1195-1205. doi: 10.1093/infdis/jis478
-
(2013)
J. Infect. Dis.
, vol.207
, pp. 1195-1205
-
-
Rerks-Ngarm, S.1
Paris, R.M.2
Chunsutthiwat, S.3
Premsri, N.4
Namwat, C.5
Bowonwatanuwong, C.6
-
215
-
-
73349094086
-
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
-
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., et al. (2009). Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209-2220. doi: 10.1056/NEJMoa0908492
-
(2009)
N. Engl. J. Med.
, vol.361
, pp. 2209-2220
-
-
Rerks-Ngarm, S.1
Pitisuttithum, P.2
Nitayaphan, S.3
Kaewkungwal, J.4
Chiu, J.5
Paris, R.6
-
216
-
-
73449147009
-
Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses
-
Reyes-Sandoval, A., Berthoud, T., Alder, N., Siani, L., Gilbert, S. C., Nicosia, A., et al. (2010). Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses. Infect. Immun. 78, 145-153. doi: 10.1128/IAI.00740-09
-
(2010)
Infect. Immun.
, vol.78
, pp. 145-153
-
-
Reyes-Sandoval, A.1
Berthoud, T.2
Alder, N.3
Siani, L.4
Gilbert, S.C.5
Nicosia, A.6
-
217
-
-
3142764761
-
Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes
-
Reyes-Sandoval, A., Fitzgerald, J. C., Grant, R., Roy, S., Xiang, Z. Q., Li, Y., et al. (2004). Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes. J. Virol. 78, 7392-7399. doi: 10.1128/JVI.78.14.7392-7399.2004
-
(2004)
J. Virol.
, vol.78
, pp. 7392-7399
-
-
Reyes-Sandoval, A.1
Fitzgerald, J.C.2
Grant, R.3
Roy, S.4
Xiang, Z.Q.5
Li, Y.6
-
218
-
-
43649106615
-
Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
-
Reyes-Sandoval, A., Sridhar, S., Berthoud, T., Moore, A. C., Harty, J. T., Gilbert, S. C., et al. (2008). Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei. Eur. J. Immunol. 38, 732-741. doi: 10.1002/eji.200737672
-
(2008)
Eur. J. Immunol.
, vol.38
, pp. 732-741
-
-
Reyes-Sandoval, A.1
Sridhar, S.2
Berthoud, T.3
Moore, A.C.4
Harty, J.T.5
Gilbert, S.C.6
-
219
-
-
77956042087
-
Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge
-
Reynolds, M. R., Weiler, A. M., Piaskowski, S. M., Kolar, H. L., Hessell, A. J., Weiker, M., et al. (2010). Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge. J. Virol. 84, 9190-9199. doi: 10.1128/JVI.00041-10
-
(2010)
J. Virol.
, vol.84
, pp. 9190-9199
-
-
Reynolds, M.R.1
Weiler, A.M.2
Piaskowski, S.M.3
Kolar, H.L.4
Hessell, A.J.5
Weiker, M.6
-
220
-
-
58149143041
-
Macaques vaccinated with live-attenuated SIV control replication of heterologous virus
-
Reynolds, M. R., Weiler, A. M., Weisgrau, K. L., Piaskowski, S. M., Furlott, J. R., Weinfurter, J. T., et al. (2008). Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J. Exp. Med. 205, 2537-2550. doi: 10.1084/jem.20081524
-
(2008)
J. Exp. Med.
, vol.205
, pp. 2537-2550
-
-
Reynolds, M.R.1
Weiler, A.M.2
Weisgrau, K.L.3
Piaskowski, S.M.4
Furlott, J.R.5
Weinfurter, J.T.6
-
221
-
-
33646586362
-
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
-
Roberts, D. M., Nanda, A., Havenga, M. J., Abbink, P., Lynch, D. M., Ewald, B. A., et al. (2006). Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 441, 239-243. doi: 10.1038/nature04721
-
(2006)
Nature
, vol.441
, pp. 239-243
-
-
Roberts, D.M.1
Nanda, A.2
Havenga, M.J.3
Abbink, P.4
Lynch, D.M.5
Ewald, B.A.6
-
222
-
-
17644419950
-
T cell vaccines for microbial infections
-
Robinson, H. L., and Amara, R. R. (2005). T cell vaccines for microbial infections. Nat. Med. 11, S25-S32. doi: 10.1038/nm1212
-
(2005)
Nat. Med.
, vol.11
, pp. S25-S32
-
-
Robinson, H.L.1
Amara, R.R.2
-
223
-
-
18244415747
-
A human immunodeficiency virus type 1 Env-granulocyte-macrophage colony-stimulating factor fusion protein enhances the cellular immune response to Env in a vaccinia virus-based vaccine
-
Rodriguez, D., Rodriguez, J. R., Llorente, M., Vazquez, I., Lucas, P., Esteban, M., et al. (1999). A human immunodeficiency virus type 1 Env-granulocyte-macrophage colony-stimulating factor fusion protein enhances the cellular immune response to Env in a vaccinia virus-based vaccine. J. Gen. Virol. 80(Pt 1), 217-223.
-
(1999)
J. Gen. Virol.
, vol.80
, pp. 217-223
-
-
Rodriguez, D.1
Rodriguez, J.R.2
Llorente, M.3
Vazquez, I.4
Lucas, P.5
Esteban, M.6
-
224
-
-
84892786095
-
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV
-
Roederer, M., Keele, B. F., Schmidt, S. D., Mason, R. D., Welles, H. C., Fischer, W., et al. (2014). Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV. Nature 505, 502-508. doi: 10.1038/nature12893
-
(2014)
Nature
, vol.505
, pp. 502-508
-
-
Roederer, M.1
Keele, B.F.2
Schmidt, S.D.3
Mason, R.D.4
Welles, H.C.5
Fischer, W.6
-
225
-
-
70349471292
-
DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge
-
Rosati, M., Bergamaschi, C., Valentin, A., Kulkarni, V., Jalah, R., Alicea, C., et al. (2009). DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc. Natl. Acad. Sci. U.S.A. 106, 15831-15836. doi: 10.1073/pnas.0902628106
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 15831-15836
-
-
Rosati, M.1
Bergamaschi, C.2
Valentin, A.3
Kulkarni, V.4
Jalah, R.5
Alicea, C.6
-
226
-
-
20744443610
-
DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge
-
Rosati, M., von Gegerfelt, A., Roth, P., Alicea, C., Valentin, A., Robert-Guroff, M., et al. (2005). DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J. Virol. 79, 8480-8492. doi: 10.1128/JVI.79.13.8480-8492.2005
-
(2005)
J. Virol.
, vol.79
, pp. 8480-8492
-
-
Rosati, M.1
von Gegerfelt, A.2
Roth, P.3
Alicea, C.4
Valentin, A.5
Robert-Guroff, M.6
-
227
-
-
17944369239
-
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
-
Rose, N. F., Marx, P. A., Luckay, A., Nixon, D. F., Moretto, W. J., Donahoe, S. M., et al. (2001). An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106, 539-549. doi: 10.1016/S0092-8674(01)00482-2
-
(2001)
Cell
, vol.106
, pp. 539-549
-
-
Rose, N.F.1
Marx, P.A.2
Luckay, A.3
Nixon, D.F.4
Moretto, W.J.5
Donahoe, S.M.6
-
228
-
-
84871284248
-
T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load
-
Roshorm, Y., Cottingham, M. G., Potash, M. J., Volsky, D. J., and Hanke, T. (2012). T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load. Eur. J. Immunol. 42, 3243-3255. doi: 10.1002/eji.201242624
-
(2012)
Eur. J. Immunol.
, vol.42
, pp. 3243-3255
-
-
Roshorm, Y.1
Cottingham, M.G.2
Potash, M.J.3
Volsky, D.J.4
Hanke, T.5
-
229
-
-
2142730100
-
Central memory and effector memory T cell subsets: function, generation, and maintenance
-
Sallusto, F., Geginat, J., and Lanzavecchia, A. (2004). Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22, 745-763. doi: 10.1146/annurev.immunol.22.012703.104702
-
(2004)
Annu. Rev. Immunol.
, vol.22
, pp. 745-763
-
-
Sallusto, F.1
Geginat, J.2
Lanzavecchia, A.3
-
230
-
-
54949106244
-
Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara
-
Sandstrom, E., Nilsson, C., Hejdeman, B., Brave, A., Bratt, G., Robb, M., et al. (2008). Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara. J. Infect. Dis. 198, 1482-1490. doi: 10.1086/592507
-
(2008)
J. Infect. Dis.
, vol.198
, pp. 1482-1490
-
-
Sandstrom, E.1
Nilsson, C.2
Hejdeman, B.3
Brave, A.4
Bratt, G.5
Robb, M.6
-
231
-
-
77949264937
-
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
-
Santra, S., Liao, H. X., Zhang, R., Muldoon, M., Watson, S., Fischer, W., et al. (2010). Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nat. Med. 16, 324-328. doi: 10.1038/nm.2108
-
(2010)
Nat. Med.
, vol.16
, pp. 324-328
-
-
Santra, S.1
Liao, H.X.2
Zhang, R.3
Muldoon, M.4
Watson, S.5
Fischer, W.6
-
232
-
-
84860837935
-
Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens
-
Santra, S., Muldoon, M., Watson, S., Buzby, A., Balachandran, H., Carlson, K. R., et al. (2012). Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens. Virology 428, 121-127. doi: 10.1016/j.virol.2012.03.012
-
(2012)
Virology
, vol.428
, pp. 121-127
-
-
Santra, S.1
Muldoon, M.2
Watson, S.3
Buzby, A.4
Balachandran, H.5
Carlson, K.R.6
-
233
-
-
79959237404
-
Newborn mice vaccination with BCG.HIVA(2)(2)(2) + MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes
-
Saubi, N., Im, E. J., Fernandez-Lloris, R., Gil, O., Cardona, P. J., Gatell, J. M., et al. (2011). Newborn mice vaccination with BCG.HIVA(2)(2)(2) + MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes. Clin. Dev. Immunol. 2011:516219. doi: 10.1155/2011/516219
-
(2011)
Clin. Dev. Immunol.
, vol.2011
, pp. 516219
-
-
Saubi, N.1
Im, E.J.2
Fernandez-Lloris, R.3
Gil, O.4
Cardona, P.J.5
Gatell, J.M.6
-
234
-
-
84865165599
-
Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG
-
Saubi, N., Mbewe-Mvula, A., Gea-Mallorqui, E., Rosario, M., Gatell, J. M., Hanke, T., et al. (2012). Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG. PLoS ONE 7:e42559. doi: 10.1371/journal.pone.0042559
-
(2012)
PLoS ONE
, vol.7
-
-
Saubi, N.1
Mbewe-Mvula, A.2
Gea-Mallorqui, E.3
Rosario, M.4
Gatell, J.M.5
Hanke, T.6
-
235
-
-
58549099671
-
Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge
-
Schell, J., Rose, N. F., Fazo, N., Marx, P. A., Hunter, M., Ramsburg, E., et al. (2009). Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge. Vaccine 27, 979-986. doi: 10.1016/j.vaccine.2008.12.017
-
(2009)
Vaccine
, vol.27
, pp. 979-986
-
-
Schell, J.1
Rose, N.F.2
Fazo, N.3
Marx, P.A.4
Hunter, M.5
Ramsburg, E.6
-
236
-
-
79958083876
-
Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen
-
Schell, J. B., Rose, N. F., Bahl, K., Diller, K., Buonocore, L., Hunter, M., et al. (2011). Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen. J. Virol. 85, 5764-5772. doi: 10.1128/JVI.00342-11
-
(2011)
J. Virol.
, vol.85
, pp. 5764-5772
-
-
Schell, J.B.1
Rose, N.F.2
Bahl, K.3
Diller, K.4
Buonocore, L.5
Hunter, M.6
-
237
-
-
0031924077
-
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
-
Schneider, J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., et al. (1998). Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4, 397-402.
-
(1998)
Nat. Med.
, vol.4
, pp. 397-402
-
-
Schneider, J.1
Gilbert, S.C.2
Blanchard, T.J.3
Hanke, T.4
Robson, K.J.5
Hannan, C.M.6
-
238
-
-
0032861392
-
Induction of CD8+ T cells using heterologous prime-boost immunisation strategies
-
Schneider, J., Gilbert, S. C., Hannan, C. M., Degano, P., Prieur, E., Sheu, E. G., et al. (1999). Induction of CD8+ T cells using heterologous prime-boost immunisation strategies. Immunol. Rev. 170, 29-38.
-
(1999)
Immunol. Rev.
, vol.170
, pp. 29-38
-
-
Schneider, J.1
Gilbert, S.C.2
Hannan, C.M.3
Degano, P.4
Prieur, E.5
Sheu, E.G.6
-
239
-
-
84859514168
-
A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults
-
Scriba, T. J., Tameris, M., Smit, E., van der Merwe, L., Hughes, E. J., Kadira, B., et al. (2012). A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults. Am. J. Respir. Crit. Care Med. 185, 769-778. doi: 10.1164/rccm.201108-1548OC
-
(2012)
Am. J. Respir. Crit. Care Med.
, vol.185
, pp. 769-778
-
-
Scriba, T.J.1
Tameris, M.2
Smit, E.3
van der Merwe, L.4
Hughes, E.J.5
Kadira, B.6
-
240
-
-
80053910021
-
Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1
-
Sedegah, M., Tamminga, C., McGrath, S., House, B., Ganeshan, H., Lejano, J., et al. (2011). Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults. PLoS ONE 6:e24586. doi: 10.1371/journal.pone.0024586
-
(2011)
Part A: safety and immunogenicity in seronegative adults. PLoS ONE
, vol.6
-
-
Sedegah, M.1
Tamminga, C.2
McGrath, S.3
House, B.4
Ganeshan, H.5
Lejano, J.6
-
241
-
-
38749096240
-
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
-
Sekaly, R. P. (2008). The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J. Exp. Med. 205, 7-12. doi: 10.1084/jem.20072681
-
(2008)
J. Exp. Med.
, vol.205
, pp. 7-12
-
-
Sekaly, R.P.1
-
242
-
-
0034730585
-
Enhancement of DNA vaccine potency by electroporation in vivo
-
Selby, M., Goldbeck, C., Pertile, T., Walsh, R., and Ulmer, J. (2000). Enhancement of DNA vaccine potency by electroporation in vivo. J. Biotechnol. 83, 147-152. doi: 10.1016/S0168-1656(00)00308-4
-
(2000)
J. Biotechnol.
, vol.83
, pp. 147-152
-
-
Selby, M.1
Goldbeck, C.2
Pertile, T.3
Walsh, R.4
Ulmer, J.5
-
243
-
-
67650917877
-
Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques
-
Sexton, A., De Rose, R., Reece, J. C., Alcantara, S., Loh, L., Moffat, J. M., et al. (2009). Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques. J. Virol. 83, 7619-7628. doi: 10.1128/JVI.00470-09
-
(2009)
J. Virol.
, vol.83
, pp. 7619-7628
-
-
Sexton, A.1
De Rose, R.2
Reece, J.C.3
Alcantara, S.4
Loh, L.5
Moffat, J.M.6
-
244
-
-
0036059866
-
Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses
-
Sharpe, S., Fooks, A., Lee, J., Hayes, K., Clegg, C., and Cranage, M. (2002). Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses. Virology 293, 210-216. doi: 10.1006/viro.2001.1281
-
(2002)
Virology
, vol.293
, pp. 210-216
-
-
Sharpe, S.1
Fooks, A.2
Lee, J.3
Hayes, K.4
Clegg, C.5
Cranage, M.6
-
245
-
-
84857399087
-
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors
-
Sheehy, S. H., Duncan, C. J., Elias, S. C., Biswas, S., Collins, K. A., O'Hara, G. A., et al. (2012). Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors. PLoS ONE 7:e31208. doi: 10.1371/journal.pone.0031208
-
(2012)
PLoS ONE
, vol.7
-
-
Sheehy, S.H.1
Duncan, C.J.2
Elias, S.C.3
Biswas, S.4
Collins, K.A.5
O'Hara, G.A.6
-
246
-
-
84860390192
-
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors
-
Sheehy, S. H., Duncan, C. J., Elias, S. C., Collins, K. A., Ewer, K. J., Spencer, A. J., et al. (2011). Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors. Mol. Ther. 19, 2269-2276. doi: 10.1038/mt.2011.176
-
(2011)
Mol. Ther.
, vol.19
, pp. 2269-2276
-
-
Sheehy, S.H.1
Duncan, C.J.2
Elias, S.C.3
Collins, K.A.4
Ewer, K.J.5
Spencer, A.J.6
-
247
-
-
84869082967
-
A vaccine strategy that protects against genital herpes by establishing local memory T cells
-
Shin, H., and Iwasaki, A. (2012). A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 491, 463-467. doi: 10.1038/nature11522
-
(2012)
Nature
, vol.491
, pp. 463-467
-
-
Shin, H.1
Iwasaki, A.2
-
248
-
-
0037122719
-
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
-
Shiver, J. W., Fu, T. M., Chen, L., Casimiro, D. R., Davies, M. E., Evans, R. K., et al. (2002). Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415, 331-335. doi: 10.1038/415331a
-
(2002)
Nature
, vol.415
, pp. 331-335
-
-
Shiver, J.W.1
Fu, T.M.2
Chen, L.3
Casimiro, D.R.4
Davies, M.E.5
Evans, R.K.6
-
249
-
-
84885460292
-
A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity
-
205ra134
-
Smaill, F., Jeyanathan, M., Smieja, M., Medina, M. F., Thanthrige-Don, N., Zganiacz, A., et al. (2013). A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity. Sci. Transl. Med. 5, 205ra134. doi: 10.1126/scitranslmed.3006843
-
(2013)
Sci. Transl. Med.
, vol.5
-
-
Smaill, F.1
Jeyanathan, M.2
Smieja, M.3
Medina, M.F.4
Thanthrige-Don, N.5
Zganiacz, A.6
-
250
-
-
0021082628
-
Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA
-
Smith, G. L., and Moss, B. (1983). Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA. Gene 25, 21-28.
-
(1983)
Gene
, vol.25
, pp. 21-28
-
-
Smith, G.L.1
Moss, B.2
-
251
-
-
79953320203
-
A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers
-
Spearman, P., Lally, M. A., Elizaga, M., Montefiori, D., Tomaras, G. D., McElrath, M. J., et al. (2011). A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers. J. Infect. Dis. 203, 1165-1173. doi: 10.1093/infdis/jiq175
-
(2011)
J. Infect. Dis.
, vol.203
, pp. 1165-1173
-
-
Spearman, P.1
Lally, M.A.2
Elizaga, M.3
Montefiori, D.4
Tomaras, G.D.5
McElrath, M.J.6
-
252
-
-
0036827820
-
Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques
-
Stevceva, L., Alvarez, X., Lackner, A. A., Tryniszewska, E., Kelsall, B., Nacsa, J., et al. (2002). Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques. J. Virol. 76, 11659-11676. doi: 10.1128/JVI.76.22.11659-11676.2002
-
(2002)
J. Virol.
, vol.76
, pp. 11659-11676
-
-
Stevceva, L.1
Alvarez, X.2
Lackner, A.A.3
Tryniszewska, E.4
Kelsall, B.5
Nacsa, J.6
-
253
-
-
79960720454
-
Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8alpha+ dendritic cell subset
-
Suleman, M., Galea, S., Gavard, F., Merillon, N., Klonjkowski, B., Tartour, E., et al. (2011). Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8alpha+ dendritic cell subset. Vaccine 29, 5892-5903. doi: 10.1016/j.vaccine.2011.06.071
-
(2011)
Vaccine
, vol.29
, pp. 5892-5903
-
-
Suleman, M.1
Galea, S.2
Gavard, F.3
Merillon, N.4
Klonjkowski, B.5
Tartour, E.6
-
254
-
-
0042389496
-
Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model
-
Takeda, A., Igarashi, H., Nakamura, H., Kano, M., Iida, A., Hirata, T., et al. (2003). Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model. J. Virol. 77, 9710-9715. doi: 10.1128/JVI.77.17.9710-9715.2003
-
(2003)
J. Virol.
, vol.77
, pp. 9710-9715
-
-
Takeda, A.1
Igarashi, H.2
Nakamura, H.3
Kano, M.4
Iida, A.5
Hirata, T.6
-
255
-
-
84896888644
-
The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
-
Tameris, M., Geldenhuys, H., Luabeya, A. K., Smit, E., Hughes, J. E., Vermaak, S., et al. (2014). The candidate TB vaccine, MVA85A, induces highly durable Th1 responses. PLoS ONE 9:e87340. doi: 10.1371/journal.pone.0087340
-
(2014)
PLoS ONE
, vol.9
-
-
Tameris, M.1
Geldenhuys, H.2
Luabeya, A.K.3
Smit, E.4
Hughes, J.E.5
Vermaak, S.6
-
256
-
-
84875382846
-
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
-
Tameris, M. D., Hatherill, M., Landry, B. S., Scriba, T. J., Snowden, M. A., Lockhart, S., et al. (2013). Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381, 1021-1028. doi: 10.1016/S0140-6736
-
(2013)
Lancet
, vol.381
, pp. 1021-1028
-
-
Tameris, M.D.1
Hatherill, M.2
Landry, B.S.3
Scriba, T.J.4
Snowden, M.A.5
Lockhart, S.6
-
257
-
-
80053894662
-
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1
-
Tamminga, C., Sedegah, M., Regis, D., Chuang, I., Epstein, J. E., Spring, M., et al. (2011). Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component. PLoS ONE 6:e25868. doi: 10.1371/journal.pone.0025868
-
(2011)
Part B: safety, immunogenicity and protective efficacy of the CSP component. PLoS ONE
, vol.6
-
-
Tamminga, C.1
Sedegah, M.2
Regis, D.3
Chuang, I.4
Epstein, J.E.5
Spring, M.6
-
258
-
-
4644318756
-
Adenoviruses as vaccine vectors
-
Tatsis, N., and Ertl, H. C. (2004). Adenoviruses as vaccine vectors. Mol. Ther. 10, 616-629. doi: 10.1016/j.ymthe.2004.07.013
-
(2004)
Mol. Ther.
, vol.10
, pp. 616-629
-
-
Tatsis, N.1
Ertl, H.C.2
-
259
-
-
34548862855
-
Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines
-
Tatsis, N., Fitzgerald, J. C., Reyes-Sandoval, A., Harris-McCoy, K. C., Hensley, S. E., Zhou, D., et al. (2007a). Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood 110, 1916-1923. doi: 10.1182/blood-2007-02-062117
-
(2007)
Blood
, vol.110
, pp. 1916-1923
-
-
Tatsis, N.1
Fitzgerald, J.C.2
Reyes-Sandoval, A.3
Harris-McCoy, K.C.4
Hensley, S.E.5
Zhou, D.6
-
260
-
-
68249108510
-
Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens
-
Tatsis, N., Lasaro, M. O., Lin, S. W., Haut, L. H., Xiang, Z. Q., Zhou, D., et al. (2009). Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens. J. Immunol. 182, 6587-6599. doi: 10.4049/jimmunol.0900317
-
(2009)
J. Immunol.
, vol.182
, pp. 6587-6599
-
-
Tatsis, N.1
Lasaro, M.O.2
Lin, S.W.3
Haut, L.H.4
Xiang, Z.Q.5
Zhou, D.6
-
261
-
-
34548770610
-
Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing
-
Tatsis, N., Lin, S. W., Harris-McCoy, K., Garber, D. A., Feinberg, M. B., and Ertl, H. C., (2007b). Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing. Virology 367, 156-167. doi: 10.1016/j.virol.2007.05.028
-
(2007)
Virology
, vol.367
, pp. 156-167
-
-
Tatsis, N.1
Lin, S.W.2
Harris-McCoy, K.3
Garber, D.A.4
Feinberg, M.B.5
Ertl, H.C.6
-
262
-
-
84868157389
-
Risk of immunodeficiency virus infection may increase with vaccine-induced immune response
-
Tenbusch, M., Ignatius, R., Temchura, V., Nabi, G., Tippler, B., Stewart-Jones, G., et al. (2012). Risk of immunodeficiency virus infection may increase with vaccine-induced immune response. J. Virol. 86, 10533-10539. doi: 10.1128/JVI.00796-12
-
(2012)
J. Virol.
, vol.86
, pp. 10533-10539
-
-
Tenbusch, M.1
Ignatius, R.2
Temchura, V.3
Nabi, G.4
Tippler, B.5
Stewart-Jones, G.6
-
263
-
-
33846964896
-
HIV-1 vaccine development: progress and prospects
-
Thorner, A. R., and Barouch, D. H. (2007). HIV-1 vaccine development: progress and prospects. Curr. Infect. Dis. Rep. 9, 71-75. doi: 10.1007/s11908-007-0025-0
-
(2007)
Curr. Infect. Dis. Rep.
, vol.9
, pp. 71-75
-
-
Thorner, A.R.1
Barouch, D.H.2
-
264
-
-
84894208460
-
A "prime-pull" vaccine strategy has a modest effect on local and systemic antibody responses to HIV gp140 in mice
-
Tregoning, J. S., Buffa, V., Oszmiana, A., Klein, K., Walters, A. A., and Shattock, R. J. (2013). A "prime-pull" vaccine strategy has a modest effect on local and systemic antibody responses to HIV gp140 in mice. PLoS ONE 8:e80559. doi: 10.1371/journal.pone.0080559
-
(2013)
PLoS ONE
, vol.8
-
-
Tregoning, J.S.1
Buffa, V.2
Oszmiana, A.3
Klein, K.4
Walters, A.A.5
Shattock, R.J.6
-
265
-
-
78649725224
-
Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies
-
Vaine, M., Wang, S., Liu, Q., Arthos, J., Montefiori, D., Goepfert, P., et al. (2010). Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies. PLoS ONE 5:e13916. doi: 10.1371/journal.pone.0013916
-
(2010)
PLoS ONE
, vol.5
-
-
Vaine, M.1
Wang, S.2
Liu, Q.3
Arthos, J.4
Montefiori, D.5
Goepfert, P.6
-
266
-
-
76949100672
-
Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit
-
Valentin, A., von Gegerfelt, A., Rosati, M., Miteloudis, G., Alicea, C., Bergamaschi, C., et al. (2010). Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit. Vaccine 28, 1962-1974. doi: 10.1016/j.vaccine.2009.10.099
-
(2010)
Vaccine
, vol.28
, pp. 1962-1974
-
-
Valentin, A.1
von Gegerfelt, A.2
Rosati, M.3
Miteloudis, G.4
Alicea, C.5
Bergamaschi, C.6
-
267
-
-
84870701546
-
Broadly neutralizing antibodies against HIV-1: templates for a vaccine
-
van Gils, M. J., and Sanders, R. W. (2013). Broadly neutralizing antibodies against HIV-1: templates for a vaccine. Virology 435, 46-56. doi: 10.1016/j.virol.2012.10.004
-
(2013)
Virology
, vol.435
, pp. 46-56
-
-
van Gils, M.J.1
Sanders, R.W.2
-
268
-
-
75249102897
-
Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV
-
Van Rompay, K. K., Abel, K., Earl, P., Kozlowski, P. A., Easlick, J., Moore, J., et al. (2010). Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV. Vaccine 28, 1481-1492. doi: 10.1016/j.vaccine.2009.11.061
-
(2010)
Vaccine
, vol.28
, pp. 1481-1492
-
-
Van Rompay, K.K.1
Abel, K.2
Earl, P.3
Kozlowski, P.A.4
Easlick, J.5
Moore, J.6
-
269
-
-
19944433130
-
Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV
-
Van Rompay, K. K., Abel, K., Lawson, J. R., Singh, R. P., Schmidt, K. A., Evans, T., et al. (2005). Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV. J. Acquir. Immune Defic. Syndr. 38, 124-134. doi: 10.1097/00126334-200502010-00002
-
(2005)
J. Acquir. Immune Defic. Syndr.
, vol.38
, pp. 124-134
-
-
Van Rompay, K.K.1
Abel, K.2
Lawson, J.R.3
Singh, R.P.4
Schmidt, K.A.5
Evans, T.6
-
270
-
-
79956061128
-
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers
-
Vasan, S., Hurley, A., Schlesinger, S. J., Hannaman, D., Gardiner, D. F., Dugin, D. P., et al. (2011). In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS ONE 6:e19252. doi: 10.1371/journal.pone.0019252
-
(2011)
PLoS ONE
, vol.6
-
-
Vasan, S.1
Hurley, A.2
Schlesinger, S.J.3
Hannaman, D.4
Gardiner, D.F.5
Dugin, D.P.6
-
271
-
-
33846830008
-
Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization
-
von Gegerfelt, A. S., Rosati, M., Alicea, C., Valentin, A., Roth, P., Bear, J., et al. (2007). Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization. J. Virol. 81, 1972-1979. doi: 10.1128/JVI.01990-06
-
(2007)
J. Virol.
, vol.81
, pp. 1972-1979
-
-
von Gegerfelt, A.S.1
Rosati, M.2
Alicea, C.3
Valentin, A.4
Roth, P.5
Bear, J.6
-
272
-
-
84885094087
-
Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1)
-
Wallace, A., West, K., Rothman, A. L., Ennis, F. A., Lu, S., and Wang, S. (2013). Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1). Hum. Vaccin. Immunother. 9, 2095-2102. doi: 10.4161/hv.26009
-
(2013)
Hum. Vaccin. Immunother.
, vol.9
, pp. 2095-2102
-
-
Wallace, A.1
West, K.2
Rothman, A.L.3
Ennis, F.A.4
Lu, S.5
Wang, S.6
-
273
-
-
33646840487
-
Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine
-
Wang, S., Farfan-Arribas, D. J., Shen, S., Chou, T. H., Hirsch, A., He, F., et al. (2006a). Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine. Vaccine 24, 4531-4540. doi: 10.1016/j.vaccine.2005.08.023
-
(2006)
Vaccine
, vol.24
, pp. 4531-4540
-
-
Wang, S.1
Farfan-Arribas, D.J.2
Shen, S.3
Chou, T.H.4
Hirsch, A.5
He, F.6
-
274
-
-
39149109930
-
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers
-
Wang, S., Kennedy, J. S., West, K., Montefiori, D. C., Coley, S., Lawrence, J., et al. (2008b). Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. Vaccine 26, 1098-1110. doi: 10.1016/j.vaccine.2007.12.024
-
(2008)
Vaccine
, vol.26
, pp. 1098-1110
-
-
Wang, S.1
Kennedy, J.S.2
West, K.3
Montefiori, D.C.4
Coley, S.5
Lawrence, J.6
-
275
-
-
33746651142
-
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E
-
Wang, S., Pal, R., Mascola, J. R., Chou, T. H., Mboudjeka, I., Shen, S., et al. (2006b). Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E. Virology 350, 34-47. doi: 10.1016/j.virol.2006.02.032
-
(2006)
Virology
, vol.350
, pp. 34-47
-
-
Wang, S.1
Pal, R.2
Mascola, J.R.3
Chou, T.H.4
Mboudjeka, I.5
Shen, S.6
-
276
-
-
41549123253
-
The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods
-
Wang, S., Zhang, C., Zhang, L., Li, J., Huang, Z., and Lu, S., (2008a). The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 26, 2100-2110. doi: 10.1016/j.vaccine.2008.02.033
-
(2008)
Vaccine
, vol.26
, pp. 2100-2110
-
-
Wang, S.1
Zhang, C.2
Zhang, L.3
Li, J.4
Huang, Z.5
Lu, S.6
-
277
-
-
4344652157
-
An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS
-
Wang, S. W., Bertley, F. M., Kozlowski, P. A., Herrmann, L., Manson, K., Mazzara, G., et al. (2004). An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS. AIDS Res. Hum. Retroviruses 20, 846-859. doi: 10.1089/0889222041725253
-
(2004)
AIDS Res. Hum. Retroviruses
, vol.20
, pp. 846-859
-
-
Wang, S.W.1
Bertley, F.M.2
Kozlowski, P.A.3
Herrmann, L.4
Manson, K.5
Mazzara, G.6
-
278
-
-
79952766781
-
Human serum amyloid P functions as a negative regulator of the innate and adaptive immune responses to DNA vaccines
-
Wang, Y., Guo, Y., Wang, X., Huang, J., Shang, J., and Sun, S. (2011). Human serum amyloid P functions as a negative regulator of the innate and adaptive immune responses to DNA vaccines. J. Immunol. 186, 2860-2870. doi: 10.4049/jimmunol.1003641
-
(2011)
J. Immunol.
, vol.186
, pp. 2860-2870
-
-
Wang, Y.1
Guo, Y.2
Wang, X.3
Huang, J.4
Shang, J.5
Sun, S.6
-
279
-
-
84855422153
-
Serum amyloid P component facilitates DNA clearance and inhibits plasmid transfection: implications for human DNA vaccine
-
Wang, Y., Guo, Y., Wang, X., Huang, J., Shang, J., and Sun, S. (2012). Serum amyloid P component facilitates DNA clearance and inhibits plasmid transfection: implications for human DNA vaccine. Gene Ther. 19, 70-77. doi: 10.1038/gt.2011.67
-
(2012)
Gene Ther.
, vol.19
, pp. 70-77
-
-
Wang, Y.1
Guo, Y.2
Wang, X.3
Huang, J.4
Shang, J.5
Sun, S.6
-
280
-
-
20144387467
-
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
-
Webster, D. P., Dunachie, S., Vuola, J. M., Berthoud, T., Keating, S., Laidlaw, S. M., et al. (2005). Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc. Natl. Acad. Sci. U.S.A. 102, 4836-4841. doi: 10.1073/pnas.0406381102
-
(2005)
Proc. Natl. Acad. Sci. U.S.A.
, vol.102
, pp. 4836-4841
-
-
Webster, D.P.1
Dunachie, S.2
Vuola, J.M.3
Berthoud, T.4
Keating, S.5
Laidlaw, S.M.6
-
281
-
-
67649980065
-
Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A
-
Whelan, K. T., Pathan, A. A., Sander, C. R., Fletcher, H. A., Poulton, I., Alder, N. C., et al. (2009). Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A. PLoS ONE 4:e5934. doi: 10.1371/journal.pone.0005934
-
(2009)
PLoS ONE
, vol.4
-
-
Whelan, K.T.1
Pathan, A.A.2
Sander, C.R.3
Fletcher, H.A.4
Poulton, I.5
Alder, N.C.6
-
282
-
-
18144446323
-
Increased DNA vaccine delivery and immunogenicity by electroporation in vivo
-
Widera, G., Austin, M., Rabussay, D., Goldbeck, C., Barnett, S. W., Chen, M., et al. (2000). Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J. Immunol. 164, 4635-4640. doi: 10.4049/jimmunol.164.9.4635
-
(2000)
J. Immunol.
, vol.164
, pp. 4635-4640
-
-
Widera, G.1
Austin, M.2
Rabussay, D.3
Goldbeck, C.4
Barnett, S.W.5
Chen, M.6
-
283
-
-
80052436008
-
Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen
-
Winstone, N., Wilson, A. J., Morrow, G., Boggiano, C., Chiuchiolo, M. J., Lopez, M., et al. (2011). Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen. J. Virol. 85, 9578-9587. doi: 10.1128/JVI.05060-11
-
(2011)
J. Virol.
, vol.85
, pp. 9578-9587
-
-
Winstone, N.1
Wilson, A.J.2
Morrow, G.3
Boggiano, C.4
Chiuchiolo, M.J.5
Lopez, M.6
-
284
-
-
0036187846
-
Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product
-
Xiang, Z., Gao, G., Reyes-Sandoval, A., Cohen, C. J., Li, Y., Bergelson, J. M., et al. (2002). Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. J. Virol. 76, 2667-2675. doi: 10.1128/JVI.76.6.2667-2675.2002
-
(2002)
J. Virol.
, vol.76
, pp. 2667-2675
-
-
Xiang, Z.1
Gao, G.2
Reyes-Sandoval, A.3
Cohen, C.J.4
Li, Y.5
Bergelson, J.M.6
-
285
-
-
33750000997
-
Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa
-
Xiang, Z., Li, Y., Cun, A., Yang, W., Ellenberg, S., Switzer, W. M., et al. (2006). Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa. Emerging Infect. Dis. 12, 1596-1599. doi: 10.3201/eid1210.060078
-
(2006)
Emerging Infect. Dis.
, vol.12
, pp. 1596-1599
-
-
Xiang, Z.1
Li, Y.2
Cun, A.3
Yang, W.4
Ellenberg, S.5
Switzer, W.M.6
-
286
-
-
0141566356
-
Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier
-
Xiang, Z. Q., Gao, G. P., Reyes-Sandoval, A., Li, Y., Wilson, J. M., and Ertl, H. C. (2003). Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier. J. Virol. 77, 10780-10789. doi: 10.1128/JVI.77.20.10780-10789.2003
-
(2003)
J. Virol.
, vol.77
, pp. 10780-10789
-
-
Xiang, Z.Q.1
Gao, G.P.2
Reyes-Sandoval, A.3
Li, Y.4
Wilson, J.M.5
Ertl, H.C.6
-
287
-
-
0029588473
-
Immune effector mechanisms required for protection to rabies virus
-
Xiang, Z. Q., Knowles, B. B., McCarrick, J. W., and Ertl, H. C. (1995). Immune effector mechanisms required for protection to rabies virus. Virology 214, 398-404. doi: 10.1006/viro.1995.0049
-
(1995)
Virology
, vol.214
, pp. 398-404
-
-
Xiang, Z.Q.1
Knowles, B.B.2
McCarrick, J.W.3
Ertl, H.C.4
-
288
-
-
0344690151
-
Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant
-
Xiang, Z. Q., Pasquini, S., and Ertl, H. C. (1999). Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant. J. Immunol. 162, 6716-6723.
-
(1999)
J. Immunol.
, vol.162
, pp. 6716-6723
-
-
Xiang, Z.Q.1
Pasquini, S.2
Ertl, H.C.3
-
289
-
-
0029951519
-
A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier
-
Xiang, Z. Q., Yang, Y., Wilson, J. M., and Ertl, H. C. (1996). A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219, 220-227. doi: 10.1006/viro.1996.0239
-
(1996)
Virology
, vol.219
, pp. 220-227
-
-
Xiang, Z.Q.1
Yang, Y.2
Wilson, J.M.3
Ertl, H.C.4
-
290
-
-
33846301454
-
Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine
-
Yan, J., Yoon, H., Kumar, S., Ramanathan, M. P., Corbitt, N., Kutzler, M., et al. (2007). Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine. Mol. Ther. 15, 411-421. doi: 10.1038/sj.mt.6300036
-
(2007)
Mol. Ther.
, vol.15
, pp. 411-421
-
-
Yan, J.1
Yoon, H.2
Kumar, S.3
Ramanathan, M.P.4
Corbitt, N.5
Kutzler, M.6
-
291
-
-
34250827007
-
Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy
-
Yang, H., Dong, T., Turnbull, E., Ranasinghe, S., Ondondo, B., Goonetilleke, N., et al. (2007c). Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy. J. Immunol. 179, 597-606. doi: 10.4049/jimmunol.179.1.597
-
(2007)
J. Immunol.
, vol.179
, pp. 597-606
-
-
Yang, H.1
Dong, T.2
Turnbull, E.3
Ranasinghe, S.4
Ondondo, B.5
Goonetilleke, N.6
-
292
-
-
0345599026
-
Detailed analysis of the CD8+ T-cell response following adenovirus vaccination
-
Yang, T. C., Dayball, K., Wan, Y. H., and Bramson, J. (2003a). Detailed analysis of the CD8+ T-cell response following adenovirus vaccination. J. Virol. 77, 13407-13411. doi: 10.1128/JVI.77.24.13407-13411.2003
-
(2003)
J. Virol.
, vol.77
, pp. 13407-13411
-
-
Yang, T.C.1
Dayball, K.2
Wan, Y.H.3
Bramson, J.4
-
293
-
-
34250325442
-
T-cell immunity generated by recombinant adenovirus vaccines
-
Yang, T. C., Millar, J. B., Grinshtein, N., Bassett, J., Finn, J., and Bramson, J. L., (2007a). T-cell immunity generated by recombinant adenovirus vaccines. Expert Rev. Vaccines 6, 347-356. doi: 10.1586/14760584.6.3.347
-
(2007)
Expert Rev. Vaccines
, vol.6
, pp. 347-356
-
-
Yang, T.C.1
Millar, J.B.2
Grinshtein, N.3
Bassett, J.4
Finn, J.5
Bramson, J.L.6
-
294
-
-
29644438544
-
The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity
-
Yang, T. C., Millar, J., Groves, T., Grinshtein, N., Parsons, R., Takenaka, S., et al. (2006). The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity. J. Immunol. 176, 200-210. doi: 10.4049/jimmunol.176.1.200
-
(2006)
J. Immunol.
, vol.176
, pp. 200-210
-
-
Yang, T.C.1
Millar, J.2
Groves, T.3
Grinshtein, N.4
Parsons, R.5
Takenaka, S.6
-
296
-
-
0037213293
-
Overcoming immunity to a viral vaccine by DNA priming before vector boosting
-
Yang, Z. Y., Wyatt, L. S., Kong, W. P., Moodie, Z., Moss, B., and Nabel, G. J., (2003b). Overcoming immunity to a viral vaccine by DNA priming before vector boosting. J. Virol. 77, 799-803. doi: 10.1128/JVI.77.1.799-803.2003
-
(2003)
J. Virol.
, vol.77
, pp. 799-803
-
-
Yang, Z.Y.1
Wyatt, L.S.2
Kong, W.P.3
Moodie, Z.4
Moss, B.5
Nabel, G.J.6
-
297
-
-
33748465749
-
Comparative analysis of tropism between canarypox (ALVAC) and vaccinia viruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage
-
Yu, Q., Jones, B., Hu, N., Chang, H., Ahmad, S., Liu, J., et al. (2006). Comparative analysis of tropism between canarypox (ALVAC) and vaccinia viruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage. Vaccine 24, 6376-6391. doi: 10.1016/j.vaccine.2006.06.011
-
(2006)
Vaccine
, vol.24
, pp. 6376-6391
-
-
Yu, Q.1
Jones, B.2
Hu, N.3
Chang, H.4
Ahmad, S.5
Liu, J.6
-
298
-
-
0041837498
-
New generation of mucosal adjuvants for the induction of protective immunity
-
Yuki, Y., and Kiyono, H. (2003). New generation of mucosal adjuvants for the induction of protective immunity. Rev. Med. Virol. 13, 293-310. doi: 10.1002/rmv.398
-
(2003)
Rev. Med. Virol.
, vol.13
, pp. 293-310
-
-
Yuki, Y.1
Kiyono, H.2
-
299
-
-
84876384167
-
Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults
-
Zhang, S., Huang, W., Zhou, X., Zhao, Q., Wang, Q., and Jia, B. (2013). Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults. J. Med. Virol. 85, 1077-1084. doi: 10.1002/jmv.23546
-
(2013)
J. Med. Virol.
, vol.85
, pp. 1077-1084
-
-
Zhang, S.1
Huang, W.2
Zhou, X.3
Zhao, Q.4
Wang, Q.5
Jia, B.6
-
300
-
-
34250869460
-
Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors
-
Zhang, X., Cassis-Ghavami, F., Eller, M., Currier, J., Slike, B. M., Chen, X., et al. (2007). Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors. J. Virol. 81, 7022-7033. doi: 10.1128/JVI.02654-06
-
(2007)
J. Virol.
, vol.81
, pp. 7022-7033
-
-
Zhang, X.1
Cassis-Ghavami, F.2
Eller, M.3
Currier, J.4
Slike, B.M.5
Chen, X.6
-
301
-
-
0034986416
-
Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages
-
Zhang, Y., Chirmule, N., Gao, G. P., Qian, R., Croyle, M., Joshi, B., et al. (2001). Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol. Ther. 697-707. doi: 10.1006/mthe.2001.0329
-
(2001)
Mol. Ther
, pp. 697-707
-
-
Zhang, Y.1
Chirmule, N.2
Gao, G.P.3
Qian, R.4
Croyle, M.5
Joshi, B.6
|